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I Introduction 1 
I Introduction 
The gap junction protein connexin 43 (Cx43) is one of the most ubiquitously expressed 
connexins in the human body 191 199 83 101. It is important for the formation of intercellular 
channels to achieve communication among cells 37 199 which for example is essential for 
myocardial contractions. Moreover, Cx43 influences different cellular processes including 
cell migration 68 204 4 38 and proliferation 30 80. Additionally, expression of Cx43 has been 
shown to be altered in certain processes that are associated with enhanced cell migration such 
as wound healing 95 or atherosclerosis 94 98 23. 
 
1 Gap Junctions 
Communication among cells in a cell assembly is essential for development, tissue repair and 
maintaining tissue homeostasis. Cell to cell communication can either be straight via agonists 
and receptors fixed at adjacent cells (juxtacrine signaling), or over short distances by growth 
factors or hormones (paracrine signaling), or over larger distances via neurotransmitters that 
are sent by nerves or via hormones (endocrine signaling). One type of direct cell to cell 
signaling is communication through intercellular channels, named gap junctions. Except for 
erythrocytes, platelets, sperms, and differentiated skeletal muscle cells, all cells show gap 
junctional communication (GJC) 199. They are important for cell to cell communication in 
various tissues including musculature 2 180, vasculature 161 58 72 15, central nervous system 134 
133
 and in the kidney 60 92 and they are required for the electrical conduction in the myocard 26 
162
 
55
. Moreover, they are involved in proliferation and differentiation, especially during 
embryonic development 172 16 54. They also play a role in the immune system, as many 
immune and haematopoietic cells express connexin proteins and are thus able to exchange 
immunological information such as the presentation of antigens 139 135. Gap junctions are 
clusters of channels which connect the cytoplasms of adjacent cells with each other enabling 
the direct exchange of ions (Na+, K+), metabolites (glucose, amino acids, nucleotides), second 
messengers (Ca2+, cAMP, IP3) and dyes (calcein) up to a molecular mass of 1.8 kilodalton 
(kDa) 91 83. Larger molecules, for example siRNA with a molecular weight of 2 – 4 kDa, have 
also been shown to be transferred via certain gap junction channels 183. Permeability and 
junctional conductance differ between gap junction channels containing various connexin 
proteins, for example cardiac gap junction channels composed of connexin 43 (Cx43) show 
five times higher permeability for the transfer of Lucifer Yellow compared to those composed 
of Cx40 182. The structure of gap junctions was first described in 1977 by Makowski using X-
ray diffraction data, electron microscopy and chemical data 120. One gap junction channel 
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consists of two hemichannels, named connexons, from adjacent cells 22 120. The hemichannel 
in turn is composed of six connexins 22 120 and can either be assembled by only one type of 
connexin proteins (homomeric) or by different types of connexins (heteromeric). Moreover, 
the gap junction channel can either be homotypic (if the two connexons are identical) or 
heterotypic (if the two connexons are different) 208 199. A certain amount of gap junction 
channels accumulate and constitute a gap junction plaque. Up to now 21 different connexins 
have been analyzed in humans 83. They are different in protein size and are named with 
suffixes according to their molecular mass in kDa, which ranges from 25 to 62 kDa 40 166. For 
example, Cx43 has a molecular mass of 43 kDa. The general structure is identical among all 
connexins. They are membrane spanning proteins containing four transmembrane domains, 
forming two extracellular and one intracellular loop. Both, the N-terminus and the C-terminus 
are intracellular 120 90 54 91. The C-terminus differs in length and amino acid (aa) composition 
among the connexins 199. As an example the structure of Cx43 is displayed in figure I.1. 
 
Figure I.1: Structure of Cx43 
Cx43 consists of an intracellular N-terminus, four transmembrane domains, two extracellular (EL) and one 
intracellular loop (IL), which together represent the channel building part, and a long cytoplasmic C-terminal 
part (modified after 50). 
 
After protein synthesis, six connexins oligomerize to one connexon in the trans-golgi 
apparatus 132 91. Afterwards, the connexons are transported via vesicles to peripheral areas of 
existing gap junction plaques at the plasma membrane, where they dock with connexons in 
the cell membrane of an adjacent cell to constitute gap junction channels. The already 
EL EL 
extracellular 
intracellular 
Plasma membrane 
 
IL 
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assembled connexons then leave the center of the plaque via vesicles followed by 
proteosomal ubiquitination, whereas the newly arrived connexons are assembled in the 
periphery of the plaque 77 40 (Figure I.2). At the gap junction sites, the cells are only about 3.5 
nm apart 120 91 208 199. The docking between the connexons involves non-covalent interactions 
between their extracellular loops, which show the highest similarity in sequence among all the 
connexins. Nevertheless, they are able to influence the selectivity of docking between 
different connexons 37 198. 
 
Figure I.2: Model of gap junction assembly 
Connexons are transported via vesicles to the plasma membrane, where they dock with counterparts in the 
plasma membrane of an adjacent cell. In this process already assembled gap junction units (green) are removed 
from the middle of the plaque into large phagocytic vesicles and new connexons (red) are assembled in the 
periphery of the plaque (modified after 40). 
 
Gap junction channels can be regulated acutely in response to various stimuli such as changes 
in voltage, pH (acidification-induced closure of cardiac gap junction channels 173 33 66) and 
connexin phosphorylation 106 107. Cell coupling is also influenced by ion concentrations, as 
high extracellular calcium concentrations cause increased gap junctional communication 76. 
There exist two models concerning the mechanisms for opening and closure of gap junction 
channels. Closure might either be achieved by a twist of the connexins 16 or by a blockade of 
the channel via the C-terminal part of the connexin, according to a ball-and-chain model 128 34. 
The first model predicts that sliding of the six connexin subunits against each other in one 
hemichannel and tilting at one end causes a rotation at the base in a clockwise direction and 
consequently closure of the channel 181 199. In the ball-and-chain model, the C-terminal part of 
the connexin protein moves toward the channel pore and binds to specific aa residues thereby 
closing it. In this context, the presence of a histidine residue at position 95 is essential, which 
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 vesicles 
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may be part of the receptor to which the C-terminus binds, presumably after protonation of 
the histidine 128. 
Mutations of connexins play a role in several diseases 197. For example, mutations in the Cx43 
gene in humans are associated with oculodentodigital dysplasia, which is an autosomal 
dominant syndrome and exhibits craniofacial (ocular, nasal, and dental) as well as limb 
dysmorphisms, spastic paraplegia, and neurodegeneration 141.  
 
2 Cx43 
One of the most ubiquitously expressed connexins in mammalian and non-mammalian cells is 
Cx43 with a molecular mass of 43 kDa 191 199 83 101. The protein consists of 382 aa 10 and the 
structure is analogous to the other connexin proteins 104. However, the cytoplasmic C-
terminus is longer than in most other connexins 106. The sequence homology of Cx43 between 
the different species is very high. Thus, it only differs in six aa between mammals and non-
mammals 185 and Cx43 of human, rat and mouse are completely homologous 10 44 200 199. In 
mammalian species it is highly expressed in the ventricular myocardium, where it is 
responsible for the synchronization of myocardial contractions 26 162 55. Consequently, specific 
deletion of Cx43 in mouse myocardium results in arrhythmia 57 166. The half-life of Cx43 in 
the plasma membrane is very short, about 1 – 3 h 129 103, required for a dynamic regulation of 
GJC. Besides being important for intercellular communication, Cx43 also influences different 
cellular processes such as cell migration 68 204 4 38, which will be described in detail in chapter 
I.3.2, and proliferation 30 80. Several studies indicate that Cx43 decreases cell proliferation. 
Thus, overexpression of Cx43 reduces the proliferation rate in several tumor cells, for 
example in Neuro2A 126, in C6 glioma 210, and in mouse MCA-10 cells 159. 
As Cx43 is an essential protein, Cx43 knockout (KO) mice die at birth due to conotruncal 
heart malformations that lead to obstruction of the right ventricular outflow tract of the heart 
and consequently prevents the regular blood flow into the lungs, which in turn causes right 
ventricular failure 154 69 212. These malformations may be due to a reduced migration of 
cardiac neural crest cells observed in embryogenesis 116. On the contrary, overexpression of 
Cx43 in neural crest cells causes embryonic cranial neural tube defects and heart 
malformations which are different from those in Cx43-deficient mice 115 41 207. 
 
2.1 Cx43: function as a channel and as an adapter 
Cx43 is important for the formation of gap junction channels to achieve GJC. The dynamic 
GJC is regulated by changes in voltage, ion concentrations and pH, which have been 
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mentioned above. Moreover, phosphorylation of the connexins by several protein kinases 93 96 
97
 
106
 
107
 
108
 
167
 are important for the regulation of GJC. These phosphorylation events can 
increase or decrease the permeability of gap junction channels or affect their assembly and 
disassembly. Phosphorylation of Cx43 seems to occur only at the cytoplasmic C-terminus as 
the intracellular loop region does not contain any known sequences, which could be 
phosphorylated, and phosphorylation of the N-terminal region of connexins has also not yet 
been reported 106 107. Phosphorylation of Cx43 differs through its life cycle 152 167. Cx43 is 
translated as a non-phosphorylated 42 kDa protein (Cx43-NP), which is then 
posttranslationally phosphorylated primarily resulting in a 44 kDa protein (Cx43-P1) and 
subsequently in a 46 kDa protein (Cx43-P2) 129. Cx43-P2 is exclusively found in gap junction 
plaques, whereas Cx43-NP is predominantly localized in the cytosol 131. In western blot 
analysis the Cx43 protein appears as a triple band, which results in one band after alkaline 
phosphatase treatment, suggesting that phosphorylation of Cx43 is one reason for these 
different Cx43 forms 130. However, 2 – 4 kDa (2000 – 4000 Da) shifts cannot appear only due 
to phosphorylation (mass of phosphate 80 Da), but rather seem to be specific phosphorylation 
events, which lead to conformational changes 105 169. Mainly serine, tyrosine, proline and 
threonine residues get phosphorylated 106 107 and known phosphorylation sites exist for 
various kinases, including v-Src, mitogen-activated protein kinases (MAPKs), protein kinase 
C (PKC), protein kinase A (PKA) and casein kinase 1 (CK1) (Figure I.3) 106 107. For example, 
phosphorylation by PKA increases GJC by upregulating connexon trafficking and assembly 
into the membrane, whereas PKC decreases GJC by phosphorylation of Ser368 and 
consequent channel closure 108 156. 
  
Figure I.3: Phosphorylation sites of the C-terminal part of Cx43  
The C-terminal part of Cx43 is phosphorylated at several serine and threonine residues by various protein 
kinases, including v-Src, mitogen-activated protein kinase (MAPK), protein kinase C (PKC) and casein kinase 1 
(CK1) (from 107). 
I Introduction 6 
Among all connexins Cx26 is the only one which has not been shown to be phosphorylated 
presumably due to its short cytoplasmic tail 179. This fact shows that phosphorylation is not 
principally required for the formation of functional gap junction channels, but rather can 
improve or decrease channel opening dependent on the specific phosphorylation site. Dunham 
et al. analyzed the functional channel forming capacity of truncated Cx43 variants, lacking the 
C-terminal part, by dual voltage-clamp technique in oocytes and showed that at least aa 1 – 
257 of Cx43 are required for the formation of functional gap junction channels 35. Thus, 
truncated Cx43 variants are able to form functional channels, but permeability and 
electrophysiological properties differ from those formed by full length Cx43. This is 
confirmed by the fact that truncation of the C-terminal part of Cx43 after aa 257 leads to a 
loss of pH sensitive channel gating 128. Interestingly, the pH sensitivity can be restored by an 
additional expression of the C-terminus alone 128. 
Besides its channel forming capacity, Cx43 also seems to have an important role as an adapter 
protein as there are several known protein-protein interaction domains on the C-terminal part 
that lead to further regulatory events 106 108 107 50 51. Structural models of Cx43 revealed that 
the fourth transmembrane domain ends at about aa 230 and consequently the cytosolic C-
terminal part consists of nearly 150 aa 168. It contains two α-helical structures at Ala311 – 
Ser325 and at Asp339 – Lys345 170 171.  
Concerning the growth inhibition effect of Cx43 mentioned above, several studies aimed to 
identify whether this is dependent on the channel forming capacity of Cx43 or on its function 
as an adapter protein. In this context, Moorby and Patel could show that blocking of Cx43 gap 
junction channels by 1-heptanol in 3T3 cells resulted in similar inhibition of cell growth 
compared to expression of non-blocked Cx43 gap junction channels 126, indicating that a 
functional channel is not required for this effect. Further on, expression of the C-terminal part 
alone in Neuro2A cells 126 and in HeLa cells 30, which both do not express Cx43 in their wild-
type forms, revealed the same growth inhibition compared to expression of the full length 
Cx43. This effect might be caused by nuclear localization of the C-terminus 30. Those studies 
demonstrate that Cx43 has gap junction independent effects on cell growth 126. Whether the 
influences on cell migration by Cx43 are gap junction dependent or independent will be 
explained in chapter I.3.2 and is part of the present study. 
 
2.2 Proteins interacting with the C-terminal part of Cx43 
Several proteins have been shown to interact with the C-terminal part of Cx43 50, including 
actin-binding proteins, such as α-actinin and drebrin 20 204; adhesion proteins, such as E-
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cadherin 46, N-cadherin 64 or Zonula occludens-1 (ZO-1) 70; and proteins that influence cell 
proliferation and migration such as cortactin 174 and the nephroblastoma overexpressed 
protein (NOV) 123 45 48. In the present study we focused on the two proteins cortactin and 
NOV, which both on the one hand show interaction with Cx43 and on the other hand interact 
with the actin cytoskeleton, consequently influencing cell migration and thus represent a 
potential link between Cx43 and increased cell migration. 
 
2.2.1 Cortactin 
The actin binding protein cortactin (previously termed p80/p85 protein) is a 65 kDa protein 
and was originally characterized as a tyrosine phosphorylated substrate in v-Src-transformed 
chicken embryo fibroblast 79 203. In SDS-PAGE it migrates as an 80/85 kDa doublet. The 
reason for the discrepancy between calculated mass and observed molecular mass in SDS-
PAGE is unclear 202. Cortactin is present in multiple cell types and its expression is enhanced 
in actin-rich cellular protrusions, namely lamellipodia, of migrating cells and cell-substratum 
adhesion sites of adherent cells 202 194. Co-staining studies using Alexa Fluor-coupled 
phalloidin, which stains F-actin filaments, and cortactin antibody revealed colocalization of 
cortactin and F-actin in the peripheral cortical region 202. Further experiments showed that 
cortactin binds efficiently to F-actin due to direct interaction between its fourth tandem repeat 
region and actin 1.  
In unstimulated cells, cortactin is present in the cytoplasm as a non-phosphorylated protein 62, 
whereas in response to growth factor stimulation (EGF, FGF or PDGF), it is phosphorylated 
at tyrosine residues and translocates to the cell membrane 203 36 201 62. 
Cortactin consists of several distinct domains including an N-terminal acidic domain (NTA) 
and a series of six complete and one partially repeated segments (called the repeat region) 1. 
At the end of the C-terminus there is a Src homology 3 (SH3) domain, which interacts with 
proline-rich regions of several cortactin-interacting proteins 202 1, including neuronal Wiscott-
Aldrich syndrome protein (N-WASP) 192, WASP-interacting protein (WIP) 84, and dynamin 2 
124
. Thus, at the SH3 domain cortactin binds to and activates N-WASP 87 and at the NTA 
region (aa 1 – 84) it binds to the actin-related protein 3 (Arp3) and subsequently activates the 
Arp2/3 complex 194 192. The Arp2/3 complex is important for the nucleation of new actin 
filaments 11 196 86 and leads to the formation of actin-rich protrusions, including invadopodia 
and lamellipodia at the leading edge of migrating cells 28. As formation of these actin 
protrusions is the initial step of directional cell migration, cortactin also enhances cell 
migration 17 65. Moreover, it has been described as a regulator for tumor cell invasion 28, 
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which depends on the formation of invadopodia and is associated with extracellular matrix 
(ECM) degradation. In this context matrix metalloproteinases (MMPs) play a crucial role 113 
53
, as they can degrade components of the ECM, including collagen, laminin, fibronectin, 
vitronectin, elastin, and proteoglycans 158. By regulating the secretion of several MMPs, such 
as MMP-2, MMP-9, and membrane type-1 matrix metalloproteinase (MT1-MMP), cortactin 
is involved in cancer cell invasion 28. MMP-2 and MMP-9 are type IV collagenases 158 and 
are also expressed in HeLa cells 209, which were used in the present study. 
Furthermore, cortactin interacts with Cx43 174 and might therefore be a link between Cx43 
and the cytoskeleton. However, which part of Cx43 interacts with cortactin is not known yet. 
In the present study we therefore wanted to observe the part of Cx43 binding to cortactin and 
whether this influences cell migration in HeLa cells. 
 
2.2.2 The nephroblastoma-overexpressed protein (NOV; CCN3) 
The 48 kDa nephroblastoma-overexpressed protein (NOV; CCN3) is one member of the CCN 
protein family. The name CCN originates from the first three identified members of this 
family namely connective tissue growth factor (CTGF), cysteine-rich (CYR61) and NOV. 
Therefore, NOV is also named CCN3 13 109. The CCN protein family consists of six members, 
which are involved in cell proliferation, migration, and differentiation. Moreover, they are 
important for angiogenesis, chondrogenesis, and wound healing 14 109 146 148. NOV is 
expressed in a wide variety of tissues including lung, heart, liver, endothelium, and muscle 
146
. NOV was discovered as an overexpressed gene in nephroblastomas induced by the 
myeloblastosis-associated virus type 1 (MAV-1) in one day old chickens 121 75. However, it 
was also the first CCN protein, shown to exhibit antiproliferative activity in tumors due to 
aberrant expression 146. An N-terminal truncated 31/32 kDa isoform of NOV was detected in 
the nucleus of HeLa cells and osteosarcoma cells and showed interaction with RNA 
polymerase II 145 146, thus it might modulate gene expression during normal development, but 
can as well function as a growth suppressor gene by blocking cells in the cell cycle 145 146. 
Moreover, NOV is involved in cell migration and remodeling of the actin cytoskeleton. It 
promotes cell migration by different mechanisms which seem to be cell-type specific. Thus, 
in sarcoma cells enhanced cell migration by NOV is associated with increased expression of 
MMP-9 at the cell surface 7, whereas in glioblastoma cells expression of MMP-3 is increased 
110
. In the breast cancer cell line MDA-MB-231 NOV enhances cell migration by 
reorganization of the actin cytoskeleton with formation of cortical actin-rich membrane 
protrusions, namely lamellipodia, which might be due to activation of the small GTPase Rac1, 
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that is increased in these membrane protrusions 165. Besides intracellular localization, NOV 
can also be found extracellularly due to a signal peptide allowing secretion of the protein 148. 
Thereby, it binds directly to specific integrin receptors and can influence cell adhesion e.g. via 
the integrins α6β1, αvβ3, and α5β1 in human venous endothelial cells (HUVEC) as well as cell 
migration e.g. via the integrins αvβ3 and α5β1 in endothelial cells 112. 
It has been assumed that NOV interacts with Cx43, as overexpression of NOV in certain 
tumors is associated with a growth inhibitory effect 146 and, likewise, overexpression of Cx43 
reduces the proliferation rate in several tumor cells as mentioned above. Indeed, confocal 
microscopy studies revealed that NOV colocalizes with Cx43 at the cell membrane 123. Later 
on, glutathione S-transferase pull-down assays and co-immunoprecipitation studies showed 
that NOV directly interacts with Cx43, namely at its C-terminal part observed with differently 
truncated Cx43 proteins in C6 glioma cells (aa 244 – 382) 45 and in Jeg3 cells (aa 257 – 382) 
48
. In this context it was also shown that Cx43 recruits NOV to gap junctional plaques, where 
they interact with each other 45. In addition, expression and also secretion of NOV is 
increased in the carcinoma cell lines C6 glioma 45 and Jeg3 48 after transfection with Cx43. 
This increase might either be due to enhanced transcription or prevented degradation of NOV 
45
. Thus, it has been supposed that the tumor-suppressive and antiproliferative effects of Cx43 
are associated with the increased expression of NOV 45 48. Recently, another group created 
different deletion mutants of the C-terminal part of Cx43 and could further specify the NOV 
binding sequence on the C-terminus of Cx43 to aa 260 – 340 165. In addition, this study 
revealed that NOV links Cx43 to the actin cytoskeleton, which might cause the influence of 
Cx43 on cell migration 165. Therefore, we wanted to clearly specify the sequence on the C-
terminus at which NOV binds to and analyze whether this interaction could influence cell 
migration in HeLa cells. 
 
3 Cell migration 
Cell motility and directional cell migration are essential for various physiological processes 
including embryonic morphogenesis, tissue repair as well as regeneration and immune 
surveillance 157. Moreover, they play a role in disease states, such as tumor invasion and 
metastasis 157. 
 
3.1 Cell migration and actin dynamics 
Cell migration is a complex process starting with cell polarization and followed by formation 
of membranous protrusions at the leading edge, which can either be broad lamellipodia or 
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spike-like filopodia or a combination of both. These protrusions are driven by actin 
polymerization. In lamellipodia the actin filaments form a branched network, whereas in 
filopodia they show long parallel bundles 157. Cell migration continues with attachment of the 
lamella to the substratum, followed by forward translocation of the cell body and detachment 
of adhesions and subsequent retraction of the cell rear 157 (Figure I.4). 
 
Figure I.4: Process of cell migration 
(a) Cell migration starts with cell polarization and formation of actin-dependent protrusions, namely broad 
lamellipodia and finger-like filopodia, at the leading edge. (b) The cell extends and forms new adhesions with 
the substratum under the leading edge and (c) consequently the cell body translocates forward through 
actomyosin-based contraction forces. (d) Retraction fibers pull the rear of the cell forward leading to 
disassembly of adhesions at the cell rear and retracting of the trailing edge (from 122). 
 
The cytoskeleton of cells consists mainly of actin and plays the major role during cell 
migration. Two forms of actin exist in the cell, on the one hand monomeric, globular actin (G-
actin) and, on the other hand, filamentous actin (F-actin). G-actin polymerizes by the 
hydrolysis of ATP and release of inorganic phosphate (Pi) to F-actin. Actin filaments are 
polarized and consist of a fast-growing (barbed) and a slow-growing (pointed) end. 
Polymerization mainly takes place at the fast-growing end 196. The protein profilin binds 
ATP-actin monomers and thus maintains a pool of G-actin within the cell. Moreover, it 
inhibits spontaneous actin nucleation and secures that the actin monomers associate only with 
barbed ends but not with pointed ends of existing actin filaments 11. Free barbed ends are 
required for actin assembly, which can either be created by uncapping or cutting of pre-
existing filaments or by de novo filament nucleation 150 196. The protein complex, which is 
responsible for this nucleation process, is the Arp2/3 complex. It consists of seven subunits 
including the actin-related proteins Arp2 and Arp3 11 150 151. The process of actin assembly 
and disassembly is displayed in figure I.5. In response to extracellular stimuli, such as 
chemotactic factors, the Rho family of small GTP-binding proteins (GTPases) is activated, 
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which subsequently leads to an activation of the Wiscott Aldrich syndrome 
protein/Suppressor of cAMP-receptor (WASP/Scar) family proteins. These in turn activate 
the Arp2/3 complex, which initiates assembly of a new actin filament by nucleation. The new 
barbed end is elongated using the profilin bound ATP-actin pool. The growing filament then 
pushes forward the plasma membrane until elongation is stopped by binding of capping 
protein. This process of actin assembly results in a branched actin network, which is seen in 
lamellipodia 21 12 11 151. Disassembly of the actin filament is initiated by the actin 
depolymerization factor (ADF)/cofilin complex, which catalyzes the hydrolysis of ATP and 
release of phosphate. Consequently, the actin branch dissociates from the existing actin 
filament. To decelerate the disassembly of actin filaments, the GTPase Rac1 can also activate 
p21-activated protein kinase (PAK), which consequently leads to phosphorylation and 
inactivation of ADF/cofilin 21 12 11 151.  
 
 
Figure I.5: Model of actin assembly and disassembly at the leading edge of motile cells  
The Rho family of GTPases activate WASP/Scar family proteins, which consequently activate the Arp2/3 
complex. This complex initiates nucleation of a new actin filament that is elongated using the profilin-bound 
ATP-actin pool until binding of capping protein. Disassembly of the actin branch is initiated by the ADF/cofilin 
complex, which catalyzes the hydrolysis of ATP leading to dissociation of the actin branch (from 151). 
 
In contrast to lamellipodia, which contain branched actin filaments, filopodia are thin (0.1 – 
0.3 µm) structures and show parallel actin filament bundles. Moreover, filopodia are 
processed differently 122. They are either embedded in or protruding from the lamellipodia 177. 
Filopodia are involved in several cellular processes including wound healing, migration and 
adhesion, the latter due to expression of integrins and cadherins at the filopodioal tips 140 47. 
Moreover, filopodia are important for the guidance towards chemoattractants, as they contain 
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receptors for several signaling molecules, and also for the neuronal growth-cone development 
42
 
56
 
122
. Furthermore, they are associated with cancer cell invasion, for example in colon 
cancer 186. In macrophages filopodia act as tentacles, which can bind particles and pull them 
to the cell body, where they form a so called phagocytic cup together with the underlying 
lamellipodia 136 88 188. The process of filopodia formation is discussed controversially. 
Currently, three different models exist: the convergent elongation model, the de novo 
nucleation model and a combination of both, which are all adequately documented and might 
therefore depend on the different cell types that were investigated. According to the 
convergent elongation model, filopodia emanate from an existing lamellipodial actin network 
and are mediated by a tip complex that contains the enabled/vasodilator-stimulated 
phosphoprotein (Ena/VASP) in the filopodial tip 177 125 56. The de novo filament nucleation 
model indicates that actin filaments in filopodia are nucleated at filopodial tips by formins, 
instead of deriving from an existing lamellipodial network 176. The protein mammalian 
diaphanous-related formin 2 (mDia2) as well as the Ena/VASP proteins are essential for 
filopodia formation and may play synergistic roles as they both prevent capping of barbed 
ends and thus initiate filopodia formation 160. The combination of both models leads to the 
following model for filopodia formation, which is displayed in figure I.6.  
 
 
Figure I.6: Model of filopodia formation 
1. Starting from the lamellipodial network, some actin filaments are prevented from capping by Ena/VASP 
and/or by mDia2 and therefore elongate further on. MDia2 is also able to generate new, unbranched actin 
filaments. 2. Myosin-X connects the parallel elongated actin filaments initiating a filopodium, which then pushes 
forward the cell membrane. IRSp53 might play a supporting role by deforming the membrane. 3. Fascin then 
incorporates into the shaft of the filopodium generating a stiff actin filament bundle. Adhesion molecules might 
be localized to the filopodial tip by myosin-X (arrow) (modified after 122). 
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Some actin filaments from the lamellipodial network are prevented from capping by 
Ena/VASP and/or by mDia2 and elongate continuously. The latter is also able to nucleate 
new, unbranched actin filaments. Myosin-X connects the parallel elongated actin filaments 
initiating a filopodium, which then pushes forward the cell membrane. The protein insulin-
receptor substrate p53 (IRSp53) might support this by deforming the membrane. The protein 
fascin then incorporates into the shaft of the filopodium generating a stiff actin filament 
bundle. Adhesion molecules might be transported to the filopodial tip by myosin-X. 
Ena/VASP and mDia2 are localized in the filopodial tip complex 122. 
The Rho family of GTPases, namely RhoA, Rac1, and Cdc42 play important roles in 
regulating the actin cytoskeleton. RhoA is involved in the formation of stress fibers and focal 
adhesions, whereas Rac1 promotes lamellipodia and Cdc42 filopodia formation 122. 
Recently, it has been shown that MAPKs are also involved in cell migration 67. The p38 
MAPKs are a subfamily of these kinases 73 and are activated by growth factors 67. They 
influence growth factor- and cytokine-stimulated cell migration in various cell types 67. Thus, 
inhibition of p38 MAPK by the specific inhibitors SB203580 or SB202190 decreases growth 
factor-stimulated cell migration of several cell types. This was observed for example in 
smooth muscle cells stimulated with PDGF, TGF-β and IL-1β 63 and in corneal epithelial cells 
treated with HGF 164. Likewise, EGF or TGF-β stimulated mouse mammary epithelial cells 
(NMuMG) 85 3 and TGF-β induced human breast cancer cells (MDA-MB-231) 3 exhibited 
diminished cell migration after inhibition of p38 MAPK. We, therefore, wanted to test 
whether the p38 MAPK pathway plays a role in Cx43 mediated cell migration. 
 
3.2 Role of Cx43 in cell migration 
It has been shown that Cx43 is involved in cell migration in several cell lines. For example, 
Cx43 is highly expressed in migrating neural crest cells during embryogenesis 68 116 and 
overexpression of Cx43 increases cell motility and directionality in these cells 204 as well as in 
C6 glioma cells 4. Likewise, downregulation of Cx43 leads to decelerated cell migration in 
neural crest cells 68 116, in mouse embryonic fibroblasts (NIH3T3) 195, and in C6 glioma cells 
4
. However, the mechanism by which Cx43 modulates cell migration and whether it is a gap 
junction dependent or independent effect remained unclear. Expression of truncated Cx43, 
lacking the C-terminal part, resulted in decreased cell migration compared to the full length 
protein in C6 glioma cells 4 and in 3T3 fibroblasts 127. The same was observed for neuronal 
migration during brain development in mice 27. These studies indicated that not the channel 
building part of Cx43 but rather the C-terminus is essential to enhance cell migration. 
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However, there exist studies showing a gap junction dependent effect of Cx43 on cell 
migration. Thus, expression of a truncated Cx43 protein, lacking the C-terminal part, 
increased migration of radial glia cells 38. Adhesive properties of the gap junction channel 
may play a role in this context because a mutated Cx43 gap junction channel, which exhibits a 
closed channel but enables adhesion, also showed enhanced radial glia migration comparable 
to wild-type Cx43 5 38. Likewise, glioblastoma cells showed decreased cell migration and 
invasion after blocking gap junctional communication with carbenoxolone (CBX) 137. 
Conversely, there are a few studies, which indicate that Cx43 decreases cell migration. For 
example, transient downregulation of Cx43 has been reported to result in an enlarged rate of 
wound closure in skin lesions 153 as well as in enhanced cell growth and migration in the 
breast carcinoma cell line Hs578T 163. 
Thus, it is evident that Cx43 influences cell migration either by increasing or decreasing, 
which may be dependent on the studied cell type.  
There are several aspects to be kept in mind, which can lead to modified cell motility. One 
aspect is the reorganization of the actin cytoskeleton and there are some hints that Cx43 
interacts with the actin cytoskeleton. Thus, neural crest cells show a parallel alignment of 
actin stress fibers, whereas downregulation of Cx43 in these cells leads to a polygonal array 
of stress fiber bundles being associated with less expression of β1 integrin and vinculin 204. 
Moreover, Cx43 colocalizes with the actin cytoskeleton itself and also with several actin-
binding proteins, including α-actinin, ezrin, IQGAP, drebrin 204, NOV 45 48, and cortactin 174. 
Thereby, it might directly or indirectly influence the actin cytoskeleton. Furthermore, it has 
been assumed that enhanced cell migration due to Cx43 expression could be associated with 
expression of N-cadherin that by itself increases cell migration, for example in the breast 
cancer cell line MCF7 61, in NIH3T3 cells 195 and in mouse neural crest cells 206, indicating a 
link between gap junction and adherens junction formation. Likewise, p38 MAPK, which is 
involved in cell migration 61, could play a role in Cx43 mediated cell migration. 
Eventually, it still has to be clarified, whether Cx43 increases or decreases cell migration and 
whether this influence depends on the channel forming part of Cx43 or its C-terminal tail. 
Moreover, the associated mechanisms remain to be elucidated.  
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4 Aim of the study 
Several physiological and pathophysiological processes, which are characterized by enhanced 
cell migration such as wound healing or atherosclerosis, are linked with increased expression 
of Cx43, for example in endothelial 95 94 and smooth muscle cells 149. Since Cx43 has been 
shown to modulate migration processes, a better understanding of the mechanisms by which 
Cx43 can affect cell migration may be helpful in developing effective therapeutic control of 
such processes. However, up to now there exist controversial data how Cx43 is affecting 
migration and, in particular, whether the migration modulating effect of Cx43 is gap junction 
dependent 137 38 or independent 127 4. 
We therefore aimed to study three aspects of Cx43 mediated modulation of cell migration: 
I. Does Cx43 exhibit stimulatory effects on cell migration and are they channel dependent 
or independent? 
II. Do interactions of Cx43 with other proteins play a role in this context? 
III. Does Cx43 influence cell migration by modulating the actin cytoskeleton and/or by 
activation of p38 MAPK? 
 
To clarify the role of Cx43 during cell migration we studied the effects of an isolated 
expression of either the channel forming part or the C-terminal part of Cx43 in HeLa cells. 
These cells were chosen as they do not express connexins in their wild-type form 82 81, but can 
be stably transfected with those. Using HeLa cells is clearly an advantage compared to other 
cell types, which endogenously express several connexins, as it has been shown that the 
knockdown of one connexin affects the expression of other connexins in the same cell 89. 
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II Materials and Methods 
1 Materials 
1.1 Chemicals 
Substance Catalog number Company 
Acrylamide 4K-Solution  
(30 %), Mix 37.5:1 A1672 
AppliChem GmbH, Darmstadt, 
Germany 
Agar A0949 AppliChem GmbH, Darmstadt, Germany 
Agarose low EEO A2114 AppliChem GmbH, Darmstadt, Germany 
Albumin fraction V A1391 AppliChem GmbH, Darmstadt, Germany 
Ammoniumpersulfat A2941 AppliChem GmbH, Darmstadt, Germany 
Aqua ad iniectabilia 3703452 B. Braun Melsungen AG, Melsungen Germany 
Boric acid A2318 AppliChem GmbH, Darmstadt, Germany 
Chemiluminescent Detection 
Kit for Horseradish peroxidase, 
Solution A and Solution B 
A3417, 1200A 
and 1200B 
AppliChem GmbH, Darmstadt, 
Germany 
Ethanol absolut A3678 AppliChem GmbH, Darmstadt, Germany 
Ethidium bromide E7637 Sigma-Aldrich GmbH, Steinheim, Germany 
Formaldehyd 37 % A0877 AppliChem GmbH, Darmstadt, 
Germany 
Glycerin waterfree A2364 AppliChem GmbH, Darmstadt, 
Germany 
Glycine  A1067 AppliChem GmbH, Darmstadt, Germany 
Isopropanol A3928 AppliChem GmbH, Darmstadt, Germany 
KCl A2939 AppliChem GmbH, Darmstadt, Germany 
KH2PO4 A591973 Merck, Darmstadt, Germany 
β-Mercaptoethanol A1108 AppliChem GmbH, Darmstadt, Germany 
Methanol A0688 AppliChem GmbH, Darmstadt, Germany 
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Na2HPO4 A3905 AppliChem GmbH, Darmstadt, Germany 
NaCl A4661 AppliChem GmbH, Darmstadt, Germany 
Nonfat dried milk powder A0830 AppliChem GmbH, Darmstadt, Germany 
SB203580 (in solution) 559398 Calbiochem, Merck kGaA, Darmstadt, Germany 
SDS ultrapure A1112 AppliChem GmbH, Darmstadt, Germany 
TEMED A1148 AppliChem GmbH, Darmstadt, Germany 
Tris A1379 
AppliChem GmbH, Darmstadt, 
Germany 
Triton X-100 789704 Boehringer, Mannheim, Germany 
Trypton (Pepton from Casein) A2208 AppliChem GmbH, Darmstadt, Germany 
Tween® 20 A1389 BioChemica, AppliChem GmbH, Darmstadt, Germany 
Western Blocking Reagent 13702000 
Roche Diagnostics GmbH, 
Mannheim, Germany 
Yeast extract A1552 AppliChem GmbH, Darmstadt, Germany 
 
1.2 Cell culture 
Material Catalog number Company 
Cell counting: Fast-Read 102 
For standardized Urine analysis BVS100H 
Biosigma S.r.l., Hycor Biomedical 
Inc., Cona, Italy 
DMEM (Dulbecco’s modified 
eagle medium) 1x cell growth 
medium 
31885 Invitrogen, Eugene, Oregon, USA 
DMSO D2650 Sigma-Aldrich GmbH, Steinheim, Germany 
Fetal bovine serum S0115 Biochrom AG, Berlin, Germany 
Micro Tube 1.5 ml 72.690 Sarstedt, Nürnbrecht, Germany 
Newborn calf serum S0125 Biochrom AG, Berlin, Germany 
Penicillin (10,000 
units/ml)/Streptomycin (10 
mg/ml) in 0.9 % NaCl solution 
P0781 Sigma-Aldrich GmbH, Steinheim, Germany 
Pipette, 5 ml, sterile  606180 Greiner bio-one GmbH, Solingen-Wald, Germany 
Pipette, 10 ml, sterile  607180 Greiner bio-one GmbH, Solingen-Wald, Germany 
Polypropylene Conical tube, 352070 Falcon, Becton Dickinson Labware, 
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Blue MaxTM, 50 ml, sterile Franklin Lakes, NJ, USA 
Polypropylene Conical tube 15 
ml, high clarity 352096 
Falcon, Becton Dickinson Labware, 
Franklin Lakes, NJ, USA 
Puromycin-Dihydrochlorid A2856 
AppliChem GmbH, Darmstadt, 
Germany 
Reaction tube 2.0 ml 710220 Biozym Scientific GmbH, Hess. Oldendorf, Germany 
Tissue culture dish, 60 x 20 mm 
Style 353004 
Falcon, Becton Dickinson Labware, 
Franklin Lakes, NJ, USA 
Tissue culture dish, 100 x 20 
mm Style 353003 
Falcon, Becton Dickinson Labware, 
Franklin Lakes, NJ, USA 
Tissue Culture Plate, 6-Well, 
Flat Bottom with low 
evaporation lid 
353224 Becton Dickinson Labware, Franklin Lakes, NJ, USA 
Tissue Culture Plate, 12-Well, 
Flat Bottom with low 
evaporation lid 
353225 Becton Dickinson Labware, Franklin Lakes, NJ, USA 
Tissue Culture Plate, 24-Well, 
Flat Bottom with low 
evaporation lid 
353226 Becton Dickinson Labware, Franklin Lakes, NJ, USA 
Trypsin-EDTA 1x T3924 Sigma-Aldrich GmbH, Steinheim, Germany 
Zeocin® R25001 Invitrogen, Carlsbad, CA, USA 
 
Solutions 
 
PBS- (Sodiumchloride solution 0.81 % in phosphate buffer 0.0067 mol/l pH 7.2) 
NaCl 8.1 g 
Na2HPO4 0.862 g 
KH2PO4 0.248 g 
Aqua ad iniectabilia ad 1.0 ml 
 
Puromycin 10 mg/ml Hepes buffer (sterile filtrated), 50 µl/500 ml DMEM medium 
 
Hepes buffer pH 7.4 
NaCl  8.473 g 
KCl  0.224 g 
Na2HPO4 x 2 H2O  0.215 g 
CaCl2 x 2 H2O  0.487 g 
MgCl x 6 H2O  0.651 g 
Hepes 1M solution   10.0 g 
Aqua ad iniectabilia ad 1000.0 g 
 
 
II Materials and Methods 19 
1.3 Fluorescent activated cell sorting 
Material Catalog number Company 
Accutase L11-007 PAA Laboratories, Pasching, Austria 
Calcein-AM C1430 Invitrogen, Carlsbad, CA, USA 
FACS Clean 340345 Becton Dickinson, BD Biosciences, San Jose, California, USA 
FACS Flow 342003 Becton Dickinson, BD Biosciences, San Jose, California, USA 
FACS Rinse 340346 Becton Dickinson, BD Biosciences, San Jose, California, USA 
FACS test tubes: Polystyrene 
round-bottom tube 352052 
Falcon, Becton Dickinson Labware, 
Franklin Lakes, NJ, USA 
PKH-26 Red Fluorescent Cell 
Linker Kit for general cell 
membrane labeling (PKH26 
GL-1KT) 
039K0781 Sigma-Aldrich GmbH, Steinheim, Germany 
 
Solutions 
Calcein-AM 1mg/ml in DMSO 
 
1.4 Migration 
Material Catalog number Company 
Culture Insert, for self insertion 80209 Ibidi, Martinsried, Germany 
µ-Dish low with culture insert, 
ibiTreat 80206 Ibidi, Martinsried, Germany 
µ-Slide 8 well, ibiTreat 80826 Ibidi, Martinsried, Germany 
 
1.5 Cloning 
Vector Catalog number Company 
pcDNA4-myc-His Version B V863-20 Invitrogen, Eugene, Oregon, USA 
pcDNA3.1-TOPO K4900-01 Invitrogen, Eugene, Oregon, USA 
 
Restriction enzyme Catalog number Company 
BamHI, Source: purified from 
Bacillus amyloliquefaciens H 
(20,000 U/ml) 
15201023 Invitrogen, Eugene, Oregon, USA 
PmeI, Source: purified from 
Pseudomonas mendocina 
(10,000 U/ml) 
R0560L New England Biolabs (NEB) GmbH, Frankfurt, Germany 
XbaI, Source: purified from 
Xanthomonas campestris 
(Xanthomonas badrii) 
(20,000 U/ml) 
15226012 Invitrogen, Eugene, Oregon, USA 
XhoI, Source: purified from 
Xanthomonas campestris 
(Xanthomonas holcicola) 
(20,000 U/ml) 
15231012 Invitrogen, Eugene, Oregon, USA 
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Polymerase Catalog number Company 
Herculase II Fusion DNA 
Polymerase 600675 
Stratagene, Agilent Technologies, 
USA 
Taq polymerase, 5 U/µl 
supplied: PCR Grade 
Nucleotide Mix, premixed 10 
mM deoxynucleotide 
triphosphate (dATP, dCTP, 
dGTP, dTTP) solution 
04728866001 
Roche Applied Science, Mannheim, 
Germany 
 
 
Gel electrophoresis 
 
TBE 10x 
Tris HCl  890 mM 
Boric acid  890 mM 
EDTA 20 mM 
Aqua dem. ad 1000 ml 
pH 8.5 
 
Gene Ruler 1 kb DNA ladder, Cat.No. SM0311, Fermentas, St. Leon-Rot, Germany 
Gene Ruler 100 bp DNA ladder plus, Cat.No. SM0321, Fermentas GmbH, St. Leon-Rot, 
Germany 
6x loading dye, Cat.No. R0611, Fermentas, St. Leon-Rot, Germany 
 
 
Bacteria 
XL1-Blue supercompetent cells, Cat.No. 200236, Stratagene, Agilent Technologies, USA 
Plates: Petri Dish, Cat.No. 663102, Greiner Bio-One, Frickenhausen, Germany 
 
LB medium 
Trypton (Pepton from Casein) 10.0 g 
Yeast extract   5.0 g 
NaCl   5.0 g 
Aqua dem. ad 1000.0 ml 
 
 
Kits for cloning Catalog number Company 
HiSpeed® Plasmid Maxi Kit 12663 Qiagen GmbH, Hilden, Germany 
QIAquick® Gel Extraction Kit 28706 Qiagen GmbH, Hilden, Germany 
QIAquick® PCR Purification 
Kit 28106 Qiagen GmbH, Hilden, Germany 
QIAprep® Spin Miniprep Kit 27106 Qiagen GmbH, Hilden, Germany 
Rapid DNA Ligation Kit 11635379001 Roche Diagnostics GmbH, Mannheim, Germany 
 
Transfection 
SuperFect Transfection Reagent, Cat.No. 301305, Qiagen GmbH, Hilden, Germany 
 
 
LB agar 
Trypton (Pepton from Casein) 10.0 g 
Yeast extract   5.0 g 
NaCl   5.0 g 
Aqua dem. ad 1000.0 ml 
Agar 12.0 g 
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1.6 Western blotting 
Separating gel 10 % 
Aqua dem. 4.0 ml 
Tris/HCl 1.5 M pH 8.8 2.5 ml 
SDS 10 %   100.0 µl 
Polyacrylamid 30 % 3.3 ml 
APS 10 %  50.0 µl 
TEMED 5.0 µl 
 
 
Tris 1.5 M pH 8.8 
Tris 90.8 g in 500 ml Aqua dem. 
 
 
Electrophoresis buffer 5x 
Tris 75.0 g 
Glycine  360.0 g 
SDS 25.0 g 
Aqua dem. ad 5000 ml 
  
 
 
Washing buffer 
PBS 1x 
Tween 0.1 % 
 
 
PBS 10x (pH 7.4) 
NaCl 80.0 g 
KCl   2.0 g 
Na2HPO4 11.5 g 
KH2PO4   2.0 g 
Aqua dem. ad 1000 ml 
 
 
Material Catalog number Company 
Amersham Hypond-P, PVDF 
membrane RPN303F 
GE Healthcare, Buckinghamshire, 
UK 
Gel blotting paper GB003 10426892 Whatman GmbH, Dassel, Germany 
Mighty Small II for 8 x 9 cm 
gels 80614935 
Amersham Biosciences, Minnesota, 
San Franscisco, USA 
Page ruler prestained, protein 
ladder SM0671 Fermentas, St. Leon-Rot, Germany 
 
 
Stacking gel 4 % 
Aqua dem. 6.0 ml 
Tris/HCl 0.5 M pH 6.8 2.5 ml 
SDS 10 %   100.0 µl 
Polyacrylamid 30 % 1.3 ml 
APS 10 %  65.0 µl 
TEMED 5.0 µl 
Western transfer buffer 
Tris 5.8 g 
Glycine 2.9 g 
SDS 10 % 3.7 ml 
Methanol 200 ml 
Aqua dem. ad 1000 ml 
Stripping buffer (pH 2.8) 
Glycine 15.01 g 
NaCl 29.22 g 
Aqua dem. ad 1000 ml 
 
Tris 0.5 M pH 6.8 
Tris 30.2 g in 500 ml Aqua dem. 
Laemmli sample buffer 
Tris  62.5 mM  
SDS 2 % 
Glycerol  25 % 
Bromphenolblau 0.01 % 
(before use add 0.5 % β-Mercaptoethanol) 
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Antibodies 
 
Primary antibodies 
 
Antibody Isotype Catalog number Company 
Calnexin Rabbit polyclonal 2433 
Cell Signaling 
Technology, Danvers, 
USA 
Cx43 Rabbit polyclonal C 6219 Sigma Alldrich, St. Louis, USA 
Cortactin (p80/85), 
clone 4F11 
Mouse monoclonal 
IgG1 
05-180 
Upstate/Millipore, 
Temecula, California, 
USA 
GAPDH 
(Glyceraldehyde-3-
phosphate 
dehydrogenase) 
clone 6C5 
Mouse monoclonal 
IgG1 
MAB 374 
Chemicon 
International/Millipore, 
Temecula, California, 
USA 
GFP Rabbit polyclonal IgG Ab 290 
Abcam, Cambridge, 
United Kingdom 
NOV (CCN3) Goat polyclonal IgG AF 1640 R&D Systems, Minneapolis, USA 
Phospho-p38 MAP 
kinase 
(Thr180/Tyr182) 
(28B10) 
Mouse monoclonal 
IgG1 
9216 
Cell Signaling 
Technology, Danvers, 
USA 
 
 
Secondary antibodies 
 
Antibody Isotype Catalog Number Company 
Anti-mouse IgG 
H&L Chain specific 
Peroxidase conjugate 
Goat 401253 
Calbiochem, Merck 
kGaA, Darmstadt, 
Germany 
Anti-rabbit IgG, 
H&L Chain specific 
Peroxidase conjugate 
Goat 401353 
Calbiochem, Merck 
kGaA, Darmstadt, 
Germany 
Anti-goat IgG, 
H&L Chain specific 
Peroxidase conjugate 
Rabbit 401515 
Calbiochem, Merck 
kGaA, Darmstadt, 
Germany 
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1.7 Immunoprecipitation 
Material Catalog number Company 
µ Columns MACS 130-042-701 Miltenyl Biotec, Auburn CA, USA 
µMACS Micro Beads, 
Protein A 120-000-396 Miltenyl Biotec, Auburn CA, USA 
µMACS Micro Beads,  
Protein G 120-000-397 Miltenyl Biotec, Auburn CA, USA 
µMACS Separation Unit 426-03 Miltenyl Biotec, Auburn CA, USA 
 
Primary antibodies 
 
Antibody Isotype Catalog number Company 
Cx43 Rabbit polyclonal C 6219 Sigma Alldrich, St. Louis, USA 
Cortactin (p80/85), 
clone 4F11 
Mouse monoclonal 
IgG1 
05-180 
Upstate/Millipore, 
Temecula, California, 
USA 
GFP Rabbit polyclonal IgG Ab 290 
Abcam, Cambridge, 
United Kingdom 
NOV (CCN3) Goat polyclonal IgG AF 1640 R&D Systems, Minneapolis, USA 
 
Solutions 
 
Triton X-100 lysis buffer (pH 8.0)  
NaCl 150 mM (0.87 g) 
Triton X-100 1 % (1 ml) 
Tris HCl  50 mM (0.60 g) 
Aqua dem. ad 100 ml 
 
1.8 Immunofluorescence 
Solutions 
 
Phosphate buffered saline (PBS+): Hank’s solution without phenol red 
NaCl  8.0 g 
KCl  0.4 g 
Mg2SO4 x 7 H2O  0.074 g 
MgCl x 6 H2O  0.074 g 
CaCl2  0.138 g 
Na2HPO4 x 2 H2O  0.15 g 
KH2PO4  0.06 g 
Glucose  1.0 g 
NaHCO3  0.3 g 
Aqua ad iniectabilia ad 1000.0 g 
 
Formaldehyde 3.7 % in PBS+ 
Triton X-100 0.1 % in PBS+ 
Immu-Mount, Cat.No. 9990402, Shandon, Pittsburgh, USA 
 
Low salt buffer 
Tris HCl 20 mM (0.24 g) 
Aqua dem. ad 100 ml 
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Antibodies 
 
Primary antibodies 
 
The same antibodies were used as for western blotting (chapter II.1.6). 
 
Secondary antibodies 
 
Antibody Source Catalog number Company 
Alexa Fluor 488  
anti-rabbit IgG Chicken A21441 
Invitrogen, Eugene, 
Oregon, USA 
Alexa Fluor 546  
anti-mouse IgG Goat A11030 
Invitrogen, Eugene, 
Oregon, USA 
 
 
1.9 Staining of the actin cytoskeleton 
Antibody Source Catalog number Company 
Alexa Fluor 488 
phalloidin 
Amanita phalloides 
mushroom A-12379 
Molecular Probes, 
Invitrogen, Eugene, 
Oregon, USA 
Alexa Fluor 546 
phalloidin 
Amanita phalloides 
mushroom A-22283 
Molecular Probes, 
Invitrogen, Eugene, 
Oregon, USA 
 
 
1.10 Lab Equipment 
Equipment Company 
BioPhotometer 6131 Eppendorf AG, Hamburg, Germany 
Block thermostat HLC BT1301 Scientific Plastics (Europe), Great Britain 
Cell incubator Binder GmbH, Tuttlingen, Germany 
Centrifuges 
Eppendorf centrifuge 5410 
Biofuge primo R 
Megafuge 1.OR 
 
Eppendorf AG, Hamburg, Germany 
Heraeus, Osterode, Germany 
Heraeus, Osterode, Germany 
FACSort 
Becton Dickinson, BD Biosciences, San 
Jose, California, USA 
Gel documentation system:  
Gel Doc 1000 Single wavelength mini-
transilluminator 
BIO-RAD Laboratories, München, 
Germany 
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Laminar flow bench: Steril VBH  REWA, Reichertshausen, Germany 
Live cell imaging 
Heating system 6: HT200 temperature 
controller, heated lid with gas incubation, 
heated plate with multi-well format, Cat.No. 
10918 
Insert for µ-Dish 35 mm low, Cat.No. 10932 
Insert for various µ-slides, Cat.No. 10933 
Gas incubation system: Unit I for CO2 and 
pressurized air, Cat.No. 10920 
 
Ibidi, Martinsried, Germany 
Microscopes 
Migration microscope: Axio Observer Z1 
Cell culture microscope: Leitz Fluovert FU 
Confocal laser scanning microsope: 
Leica TCS SP5 
 
Carl Zeiss GmbH, Jena, Germany 
Leica Microsystems, Wetzlar, Germany 
 
Leica Microsystems, Wetzlar, Germany 
PCR thermal cycler, V2.600 Eppendorf, Hamburg, Germany 
pH meter: S20-SevenEasyTM pH Mettler Toledo, Giessen, Germany 
Power Supply 
SDS gel electrophoresis: 
Standard Power Pack P25 
Agarose gel electrophoresis:  
Gibco BRL PS305 
 
 
Biometra GmbH, Göttinge, Germany 
 
Life technologies, Darmstadt, Germany 
Sonicator Ultrasonic processor XL 
Heat Systems, Reichshof/Wenrath, 
Germany 
UV surface emitting diode H. Faust GmbH, Meckenheim, Germany 
Waterbath SWB 25 Thermo Haake GmbH, Karlsruhe, Germany 
Westernblot Detector: 
Camera Controller Orca ER 
Hamamatsu Photonics, Hamamatsu City, 
Shizuoka Pref, Japan 
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2 Methods 
2.1 Cell biological methods 
2.1.1 Cell culture 
2.1.1.1 Cell lines 
In this work HeLa wild-type (wt) cells were used, which are immortal cervix carcinoma cells 
originally isolated from the patient Henrietta Lacks in 1951. They do not express any 
connexins, but can be stably transfected with those. HeLa wt cells and HeLa cells stably 
expressing Cx43 (HeLa 43) were a kind gift from Dr. Klaus Willecke (University of Bonn, 
Germany). Furthermore, various HeLa cell lines, stably expressing the full length Cx43 
protein tagged with GFP or differently truncated Cx43 proteins, tagged with GFP, were 
generated in the present study (Table II.1). As controls, cells were transfected with the empty 
vector pcDNA4-myc-His Version B (Invitrogen) (HeLa CTL) or with a cDNA encoding GFP 
alone (HeLa GFP). 
 
Table II.1: In the present study generated HeLa cell lines by stable transfection 
Cell line Transfected plasmid 
HeLa CTL pcDNA4-myc-His Version B (Invitrogen) 
HeLa GFP pcDNA4-GFP 
HeLa 43-GFP 
pcDNA4-rCx43-GFP  
(full length rat Cx43, aa 1 – 382, GFP-tagged) 
HeLa 43NT-GFP 
pcDNA4-rCx43NT-GFP  
(N-terminal part of rat Cx43, aa 1 – 257, GFP-tagged) 
HeLa 43CT-GFP 
pcDNA4-rCx43CT-GFP  
(C-terminal part of rat Cx43, aa 257 – 382, GFP-tagged) 
HeLa 43(tr298)-GFP 
pcDNA4-rCx43(tr298)-GFP  
(truncated rat Cx43, aa 1 – 298, GFP-tagged) 
HeLa 43(tr336)-GFP 
pcDNA4-rCx43(tr336)-GFP  
(truncated rat Cx43, aa 1 – 336, GFP-tagged) 
HeLa 43(299 – 336)-GFP 
pcDNA4-rCx43(299 – 336)-GFP  
(truncated rat Cx43, aa 299 – 336, GFP-tagged) 
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2.1.1.2 Cell passaging 
Cells were cultivated in an incubator with a humidified atmosphere at 37 °C and 5 % CO2. All 
workflows in the cell culture were done in a laminar flow bench under sterile conditions. 
HeLa wt cells were maintained in Dulbecco’s modified Eagle medium (DMEM) 
supplemented with 10 % new born calf serum (NBCS) and the antibiotics penicillin (100 
U/ml) and streptomycin (100 µg/ml). Culture medium of HeLa 43 cells additionally contained 
puromycin (1 µg/ml) due to a vector encoded puromycin resistance. Cells, which were 
generated in the present study, were cultivated in culture medium for HeLa wt cells 
supplemented with Zeocin (200 µg/ml) due to an encoded Zeocin resistance on the vector 
pcDNA4. 
Cells were grown in cell culture dishes (100 mm in diameter) and split twice a week after 
reaching confluence. For that purpose they were washed with phosphate buffered saline 
without magnesium and calcium ions (PBS-). Subsequently, to detach cells from the bottom 
of the culture dish, a solution containing 0.5 % trypsin and 0.2 % EDTA was added. To 
deactivate the trypsin, cell culture medium was added and the cells were resuspended. 
According to the required amount of cells, the cell suspension was transferred to new cell 
culture dishes and diluted to the desired concentration with fresh cell culture medium. 
 
PBS- 
NaCl 8.1 g 
Na2HPO4 0.862 g 
KH2PO4 0.248 g 
Aqua ad iniectabilia  ad 1.0 ml 
 
2.1.1.3 Cell freezing 
Cells were grown until confluence, washed with PBS- and were detached by adding 1 ml 
trypsin/EDTA solution. The cells were resuspended in an appropriate amount of freezing 
medium (cell culture medium supplemented with 20 % NBCS and 10 % DMSO) and the cell 
suspension was added to cryovials. The cryovials were frozen at -80 °C for 24 h and 
afterwards placed in a liquid nitrogen tank (-196 °C) for long time storage. 
 
2.1.1.4 Cell thawing 
The frozen cells were thawed quickly in a 37 °C water bath. The cell suspension was mixed 
with fresh cell culture medium, centrifuged at 1200 rpm for 5 min and the cell pellet was 
resuspended in fresh cell culture medium to remove the DMSO. The cell suspension was 
transferred into a new cell culture dish and fresh cell culture medium was added. 
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2.1.2 Lethality curve 
To determine the optimal concentration of Zeocin in the cell culture medium for generation of 
stably transfected cells, a lethality curve was performed. HeLa wt cells were seeded in a 6-
well-plate at a dilution of 4 x 105 cells/ml. After appropriate attachment of the cells, the 
following Zeocin concentrations were added: 0, 100, 150, 200, 250 and 300 µg/ml. Cells were 
cultivated for 10 days and the media were changed every two days. The lowest Zeocin 
concentration, sufficient to kill all cells after 10 days, was used to produce stably transfected 
cell lines. In the present study a Zeocin concentration of 200 µg/ml was used. 
 
2.1.3 Transfection of HeLa wt cells 
Transfection of cells is a powerful tool to study and control gene expression. During the 
process of transfection, foreign DNA is delivered into eukaryotic cells. Two transfection 
techniques can be distinguished: transient and stable transfection. Using transient transfection, 
the DNA is introduced into the nucleus of the cell, but does not integrate into the 
chromosomal DNA. Consequently, a lot of copies of the transfected gene are present leading 
to high levels of expressed protein, which can be observed within 24 – 96 h after introduction 
of the DNA. 
Using stable transfection, the DNA is either integrated into the chromosomal DNA or 
maintained as an episome. Cells which have integrated the transfected DNA or have 
generated episomal plasmid DNA can be selected as single cell clones using a vector encoded 
resistance against a specific antibiotic. In the present study SuperFect transfection reagent 
(Qiagen) was used, which optimizes the entry of DNA into the cell (first described by 178). 
Preparation of DNA and SuperFect transfection reagent should be done in serum-free medium 
because serum may inhibit complex formation. 
 
2.1.3.1 Transient transfection of HeLa wt cells 
Transient transfection was performed to observe whether the constructed plasmid leads to 
expression of the respective protein within the cell. Expression of GFP-tagged proteins was 
either visually monitored in living cells by fluorescence of the GFP-tag using laser scanning 
microscopy (LSM; Leica) or cell extracts were investigated by western blot analysis (WB). 
HeLa wt cells were seeded on glass cover slips (15 mm diameter) in a 12-well-plate, reaching 
50 % confluence the next day (for observation by LSM) or they were seeded in a 6-well-plate, 
reaching 60 – 70 % confluence the next day (for observation by WB). The respective 
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transfection protocols according to the manufacturer’s instructions and own experiences are 
listed in table II.2. 
 
Table II.2: Transfection protocol for transient transfection 
Substance Amount for transient 
transfection and 
observation using LSM 
Amount for transient 
transfection and 
observation using WB 
Plasmid DNA        1.0 µg          2.0 µg 
DMEM medium without 
serum and antibiotics 
ad 75.0 µl ad 100.0 µl 
SuperFect transfection reagent 
      7.5 µl        10.0 µl 
Cell culture medium for HeLa 
wt cells 
  400.0 µl      600.0 µl 
 
For transfection, the plasmid DNA was diluted in DMEM medium without serum and 
antibiotics in a 1.5 ml tube, vortexed and shortly centrifuged. SuperFect transfection reagent 
was added, mixed by pipetting up and down and incubated for 10 min at room temperature to 
allow transfection complex formation. In the meantime the medium of the cells was removed 
and they were washed twice with PBS-. The required amount of cell culture medium for HeLa 
wt cells was added to the mixture and the whole solution was transferred to the cells. 
After incubation for 24 h at 37 °C and 5 % CO2, the medium was removed and the cells were 
washed three times with PBS-. Protein expression of the transfected plasmid DNA was 
observed either by fluorescence of the GFP-tag using LSM by placing the glass cover slips in 
a special fitting for the microscope or cells were lysed in 100 µl Laemmli sample buffer 99 and 
expression of the proteins was detected using WB. 
 
2.1.3.2 Stable transfection of HeLa wt cells 
Stable transfection was performed to reach a permanent expression of the respective protein in 
all transfected cells as a necessary prerequisite for long term investigations and functional 
analyses. 
For stable transfection, HeLa wt cells were seeded in a 60 mm cell culture plate, reaching 50 
% confluence the next day (transfection protocol is listed in table II.3) and cells were 
transfected as described in chapter II.2.1.3.1 
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Table II.3: Transfection protocol for stable transfection 
Substance Amount 
Plasmid DNA          5.0 µg 
DMEM medium without serum and antibiotics ad 150.0 µl 
SuperFect transfection reagent        50.0 µl 
Cell culture medium for HeLa wt cells    1000.0 µl 
 
After further incubation for 24 h, cells were detached with 500 µl trypsin/EDTA solution and 
transferred to a new 100 mm cell culture plate in 12 ml of fresh cell culture medium 
supplemented with 200 µg/ml Zeocin. Cells got fresh cell culture medium twice a week until 
single cell clones were visible. Approximately 12 single cell clones per culture dish were 
picked using a 1000 µl sterile pipet tip and grown separately in a 24-well-plate until 
confluence. Single cell clones were expanded and investigated for their protein expression 
using western blot. Localization of the protein was analyzed by fluorescence of the GFP-tag 
using LSM. 
 
2.1.4 Analysis of cell coupling using fluorescent activated cell sorting (FACS) 
To analyze cell coupling, fluorescent activated cell sorting (FACS) was used. With this 
method, it is possible to measure fluorescent labeled single cells in a focused stream of fluid 
that pass a laser beam. Additional detectors measuring in line with the light beam (forward 
scatter, FSC) reveal the cell volume and detectors measuring perpendicular to it (side scatter, 
SSC) reveal the inner constitution of the cell, such as amount and type of cytoplasmic 
granules (Figure II.1). Therefore, it is possible to characterize different cell populations and 
sort them according to specific characteristics. In this study the FACSort (Becton Dickinson) 
was used, equipped with an argon laser, exhibiting an excitation wavelength of 488 nm, and 
able to measure green (FL-1) and red (FL-2) fluorescence at emission wavelengths of 530 and 
585 nm, respectively. It was connected to a computer and data was analyzed using the 
CellQuest software (Becton Dickinson). 
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Figure II.1: Principle of fluorescent activated cell sorting 
Fluorescence of single cells in a focused stream of fluid can be excited by a laser and emission can be detected 
by photomultiplier tubes (PMT) for green and red fluorescence. Additional detectors measuring volume (forward 
scatter, FSC) and inner constitution of the cell (side scatter, SSC), respectively, allow sorting of the cells 
according to specific characteristics. 
 
For analysis of cell coupling, HeLa CTL, HeLa 43, HeLa 43-GFP, HeLa 43NT-GFP and 
HeLa 43CT-GFP cells (dye donor cells) were seeded in 6-well-plates. The next day, these 
cells were washed twice with PBS- and stained with calcein-AM (final concentration: 0.2 µM; 
Invitrogen) for 30 min at 37 °C and 5 % CO2. Calcein-AM is a membrane permeant 
nonfluorescent molecule. After diffusion into the cell, it is hydrolyzed by esterases (Figure 
II.2) and cannot further permeate the cell membrane except when it is transferred by gap 
junctions. Calcein binding to intracellular calcium ions results in a fluorescent complex with 
an excitation wavelength of 495 nm and an emission wavelength of 515 nm. 
 
Figure II.2: Hydrolysis of calcein-AM  
Calcein-AM is able to penetrate the cell membrane and, after hydrolysis by intracellular esterases to calcein, 
remains in the cytosol of the cell and can be detected by excitation at 495 nm. 
 
After staining, the cells were washed four times with PBS- and incubated for 2 h at 37 °C and 
5 % CO2. A second cell population (dye acceptor cells), HeLa 43 cells, cultivated in a 100 
mm culture dish, was stained with PKH26 Red Fluorescent Cell Linker Kit (Sigma). PKH26 
Stream of 
fluid 
containing 
fluorescent 
labeled cells 
Laser 
Forward Scatter 
Side Scatter 
Red PMT 
Green PMT 
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is a fluorescent dye, which is incorporated into lipid regions of the cell membrane and can 
therefore not be transferred through gap junction channels. Its excitation maximum is at 551 
nm, but it can also be excited at 488 nm, and its emission maximum is at 567 nm. Cells were 
washed with PBS- and 500 µl of Diluent C were added. 500 µl Diluent C and 3 µl PKH26 
were mixed and transferred dropwise to the cells. After incubation for 3 min at 37 °C and 5 % 
CO2, the staining reaction was stopped by adding 1 ml fetal calf serum (FCS). Subsequently, 
the cells were incubated in 10 ml cell culture medium for 2 h at 37 °C and 5 % CO2. The cells 
were then trypsinized and resuspended in cell culture medium and a cell suspension of 
140,000 cells/ml was prepared. 2 ml of this suspension were added to each well of calcein 
stained cells and cocultured for 3 h at 37 °C and 5 % CO2. As controls, the calcein stained 
cells alone (0 h of coculture) and PKH26 stained HeLa 43 cells alone were used. 
After coculture, the supernatants of each well were transferred to 15 ml Falcon tubes. The 
adherent cells were washed with PBS- and detached with 500 µl accutase. Accutase instead of 
trypsin was used, as it causes single isolated cells, which is important for the FACS 
measurement. The detached cells were resuspended in 5 ml cell culture medium and 
transferred to the supernatants in the appropriate Falcon tube. After centrifugation (1200 rpm; 
5 min), the pellets were resuspended in 500 µl cell culture medium and transferred to FACS 
test tubes. 10,000 cells of each sample were analyzed by measuring the fluorescence of 
calcein stained (dye donor) cells as well as of PKH26 stained (dye acceptor) HeLa 43 cells at 
an excitation wavelength of 488 nm. Emission light of calcein and PKH26 was determined at 
530 (FL-1) and 585 nm (FL-2), respectively. 
The red stained HeLa 43 cells were selected and the fraction of double stained (red and green) 
cells, representing the amount of cells which were functionally coupled via gap junctions, was 
calculated. 
 
2.1.5 Analysis of cell migration 
Cell migration was analyzed using cell culture inserts for wound healing (Ibidi). A cell 
suspension of 9 x 105 cells/ml was prepared in cell culture medium containing only 0.5 % 
NBCS. 70 µl of this cell suspension were transferred into both wells of a silicone insert 
(growth area 0.22 cm2 per well; Figure II.3), which was placed in a 35 mm culture dish. The 
next day, after appropriate cell attachment, the insert was removed using sterile tweezers, 
creating a defined cell free gap of approximately 500 (± 50) µm between both cell 
populations. Cell migration into the cell free gap was started by adding cell culture medium 
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containing 10 % NBCS and observed for 24 h by live cell imaging using time lapse 
microscopy. 
 
Figure II.3: Schematic illustration of cell culture inserts (Ibidi) 
Cells were plated in the two wells of the insert. After cell adhesion, the insert was removed using sterile tweezers 
and the cells migrated into the defined cell free gap (modified after Ibidi manual for culture inserts: 
http://www.ibidi.com/products/disposables/E_8XXXX_CultureInsert/IN_8XXXX_CI.pdf). 
 
For that purpose, a microscope (Zeiss Axio observer) was equipped with a life cell imaging 
system (Ibidi) composed of a heating system and a gas mixer, which allowed controlled 
culture conditions with a humidified atmosphere at 37 °C and 5 % CO2 (Figure II.4). 
 
Figure II.4: Experimental settings for live cell imaging 
A: Schematic illustration of the gas flow in the heated stage (Ibidi application manual), B: Schematic illustration 
of the experimental settings (modified after Ibidi application manual), C: Image of the experimental settings. 
A 
 
Air 
humidity sensor 
CO2 
heating stage 
humidity column 
temperature controller 
active gas mixer 
B 
C 
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The microscope was connected to a computer equipped with the AxioVision software (Zeiss) 
and images were taken with an AxioCam camera (Zeiss) every 10 min for 24 h. For assay 
analysis, cells were tracked using the manual tracking software component of the ImageJ 
programme. After tracking, the cell paths were analyzed using the Chemotaxis and Migration 
tool, a free ImageJ plugin provided by Ibidi to compute the following parameters: center of 
mass (center of mass of all endpoints), accumulated distance (mean distance of all cell paths), 
euclidian distance (direct connection from starting point to end point), directionality, and 
velocity. Directionality was calculated by dividing euclidian distance by accumulated 
distance. The closer this value was towards 1, the higher directionality the cells had shown 
during migration. Velocity of the cells was calculated by dividing accumulated distance (in 
µm) by migration time (in sec). 
 
2.2 Cloning of cDNAs encoding truncated Cx43 proteins 
For cloning of cDNAs encoding truncated Cx43 proteins, the vector pcDNA4-myc-His 
Version B (Invitrogen) or the plasmid pcDNA4-GFP was used (Figure II.5). 
The GFP plasmid pcDNA4-GFP was generated by amplification and subcloning of the open 
reading frame of the green fluorescent protein (GFP; variant sg143GFP) by PCR from the 
plasmid pFred143, which has been published previously 175 117, into the vector pcDNA4-myc-
His Version B using the restriction enzymes XbaI and PmeI. Consequently, the myc-His-tag 
was no longer expressed. For the plasmids Cx43(tr299)-GFP, Cx43(tr336)-GFP, and 
Cx43(299-336)-GFP, GFP was amplified and subcloned without the first ATG start-codon. 
The cDNAs encoding truncated Cx43 proteins without a stop-codon were cloned into the 
pcDNA4-GFP vector using the restriction enzymes BamHI and XhoI to ensure a continuous 
transcription of Cx43 fragments coupled with GFP. 
 
Figure II.5: Modified vector map of pcDNA4-myc-His Version B (Invitrogen) 
Unique restriction sites, used for insertion of DNA fragments encoding Cx43 or truncated Cx43 proteins 
(BamHI; XhoI) and GFP (XbaI; PmeI), are displayed (red boxes). 
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2.2.1 Preparation of plasmid DNA 
The plasmid DNA was augmented by bacterial transformation using LB agar plates 
containing 100 µg/ml ampicillin and one bacterial colony was incubated in LB medium 8, 
supplemented with 100 µg/ml ampicillin, overnight for amplification. Plasmid DNA was 
isolated from bacterial cells using either Qiaprep Spin Miniprep (15 – 20 µg DNA) or 
Hispeed Plasmid Maxi Kit (400 – 500 µg DNA) according to the manufacturer’s protocol 
(Qiagen). In both isolation methods the plasmid DNA is, after alkaline lysis, bound to an 
anion-exchange resin in a column and impurities such as RNA and proteins are removed by 
several washing steps. 
 
2.2.2 Polymerase chain reaction (PCR) 
The polymerase chain reaction (PCR) allows amplification of a specific target DNA out of a 
pool of DNA. Two specific primers, complementary to the 3´ ends of sense and anti-sense 
strands of the target DNA, bind to the DNA strands and are elongated by a DNA polymerase 
in repeated cycles of three major steps: DNA denaturation, primer annealing and primer 
elongation. 
The cDNAs, encoding the truncated proteins of Cx43, were all synthesized by PCR using rat 
Cx43 cDNA as template and self-designed primer pairs (Table II.4). Unique restriction sites 
are underlined and the start-codon ATG is in bold. 
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Table II.4: Created cDNAs and primer pairs used for PCR; restriction enzymes for cloning; expected protein mass and number of base pairs of the 
cDNAs is displayed 
 
 
 
 
 
cDNA Forward primer 
5´ → 3´ 
Revers primer 
5´ → 3´ 
Restriction 
enzymes 
Protein mass 
[kDa] 
Number of 
base pairs [bp] 
rCx43  
(aa 1 – 382) 
CTC GGA TCC ATG GGT GAC 
TGG AGT 
CGA CTC GAG CGA ATC TCC 
AGG TCA TC 
BamH1; XhoI 69.9 
(with GFP-tag) 
1146 
rCx43NT  
(aa 1 – 257) 
CTC GGA TCC ATG GGT GAC 
TGG AGT 
GCT CTC GAG TGA TGG GCT 
CAG TGG 
BamH1; XhoI 55.4  
(with GFP-tag) 
771 
rCx43CT 
(aa 257 – 382) 
GCC ATG TCA AAA GAC TGC 
GGA 
AAT CTC CAG GTC ATC AGG 
CCG 
BamH1; XhoI 40.8  
(with GFP-tag) 
375 
rCx43(tr298) 
(aa 1 – 298) 
CTC GGA TCC ATG GGT GAC 
TGG AGT 
GCT CTC GAG CGG CAC GAG 
GAA TTG TT 
BamH1; XhoI 60.0  
(with GFP-tag) 
894 
rCx43(tr336) 
(aa 1 – 336) 
CTC GGA TCC ATG GGT GAC 
TGG AGT 
AAT CTC GAG CGA TCG AAC 
GGC TGG GC 
BamH1; XhoI 64.2  
(with GFP-tag) 
1008  
rCx43(299–336)  
(aa 299 – 336) 
GCT GGA TCC ATG CGC AAT 
TAC AAC AAG 
AAT CTC GAG CG ATC GAA 
CGG CTG GGC 
BamH1; XhoI 30.1  
(with GFP-tag) 
111 
GFP GAC GA TCT AGA G ATG GCT 
AGT TCC GGA GGT 
CGA G GT TTA AAC TCA 
ACC GTA CAG CTC GTC 
Xba1; Pme1 26.9 741 
GFP without 
start-codon ATG 
GAC GA TCT AGA G GCT AGT 
TCC GGA GGT 
CGA G GT TTA AAC TCA 
ACC GTA CAG CTC GTC 
Xba1; Pme1 26.8 738 
II Materials and Methods 37 
PCR was performed using standard protocols (PCR protocol is listed in table II.5, PCR 
settings are listed in table II.6. Herculase was used as DNA polymerase because of its proof-
reading capability. 
 
Table II.5: PCR protocol 
Substance Amount [µl] 
Template DNA rCx43 (1µg/µl)   1.0 
Primer forward (100 pm/µl)   2.0 
Primer revers (100 pm/µl)   2.0 
dNTPs (10 mM)   1.5 
Herculase buffer (5x) 10.0 
Herculase   1.0 
Aqua ad iniectabilia 32.5 
 
Table II.6: PCR settings 
Step Temperature [°C] Duration Number of cycles 
Initial denaturation of the DNA 
template 
95   2 min 
1 
Denaturation of synthesized 
DNA strands 
95 20 sec 
Primer annealing 60 15 sec 
Primer elongation 72 30 sec 
 
30 
Final elongation 72   3 min 1 
 
The optimal temperature for primer annealing was adjusted to the appropriate primer pairs by 
performing a gradient PCR with different temperatures in the range of 55 – 65 °C. Elongation 
time of 30 sec was sufficient for all cDNA constructs. 
 
2.2.3 Agarose gel electrophoresis 
The PCR product was determined by agarose gel electrophoresis, which reveals a single band 
due to amplification of a single segment of the target DNA. 1 % agarose was dissolved in 
TBE 1x buffer by heating the solution in a microwave for about 2 – 3 min until the agarose 
was completely solved. Subsequently, the solution was cooled down to 40 – 50 °C and, after 
addition of ethidium bromide (0.05 µg/ml), filled in a gel electrophoresis chamber. After gel 
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polymerization, 5 µl of the PCR product was mixed with 1 µl of 6x sample buffer and loaded 
onto the gel together with a 1 kb gene ruler and, for the analysis of small PCR products, with 
a 100 bp gene ruler. Electrophoresis was performed at 90 volts (1.1 V/cm2) for 45 min and the 
separated DNA was observed under UV light and pictures were taken with the gel 
documentation system (Gel Doc 1000; BIO-RAD Laboratories). 
 
TBE 10x 
Tris HCl  890 mM 
Boric acid  890 mM 
EDTA 20 mM 
Aqua dem. ad 1000 ml 
pH 8.5 
 
2.2.4 Purification of the PCR product  
The PCR product was purified using the Qiaquick PCR purification kit (Qiagen) according to 
the manufacturer’s protocol. Briefly, the DNA is bound to a silica membrane and primers, 
nucleotides, salt and other impurities are removed by several washing steps. Subsequently, the 
DNA is eluted from the membrane. 
 
2.2.5 Digestion of DNA with restriction enzymes 
The purified PCR product and also the vector pcDNA4-GFP were both digested overnight at 
37 °C using the restriction enzymes BamHI and XhoI as specified in tables II.7 and II.8. 
 
Table II.7: Protocol for digestion of the PCR product 
Substance Amount 
PCR product        4.0 µg 
BamHI (20,000 U/ml)        0.5 µl 
XhoI (20,000 U/ml)        0.5 µl 
Enzyme buffer 10x (NEB buffer 3)        6.0 µl 
BSA 10x        6.0 µl 
Aqua ad iniectabilia ad 60.0 µl 
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Table II.8: Protocol for digestion of the pcDNA4-GFP vector 
Substance Amount 
Vector pcDNA4-GFP        1.0 µg 
BamHI (20,000 U/ml)        0.5 µl 
XhoI (20,000 U/ml)        0.5 µl 
Enzyme buffer 10x (NEB buffer 3)        2.0 µl 
BSA 10x        2.0 µl 
Aqua ad iniectabilia ad 20.0 µl 
 
2.2.6 Isolation of DNA from agarose gels 
Digested DNA of PCR product and vector were separated by agarose gel electrophoresis (1 % 
agarose gel). Extraction and purification of DNA fragments from the agarose gel were 
performed using the Qiaquick gel extraction kit (Qiagen) according to the manufacturer’s 
protocol. DNA concentration was measured photometrically at 260 nm due to emission 
maximum of the DNA bases at this wavelength. Additional measurement at 280 nm allowed 
evaluation of the purity, as for example proteins which could remain after DNA purification 
show an emission maximum at this wavelength. The quotient of the value at 260 nm/value at 
280 nm had to be in the range of 1.8 – 2.0 to consider the DNA as sufficiently pure. 
 
2.2.7 DNA ligation 
DNA ligation was used to insert DNA fragments of Cx43 into the vector pcDNA4-GFP. The 
mechanism of a DNA ligase is to form phosphodiester bonds between the 3´ hydroxyl ends of 
one nucleotide with the 5´ phosphate ends of another. This results in covalent binding of 
vector and DNA fragment. To ligate vector and DNA, both were digested with the same 
restriction enzymes to generate compatible DNA overhangs. For DNA ligation the rapid DNA 
ligation kit (Roche) including a T4 DNA ligase was used according to the manufacturer’s 
protocol. The molar ratio of vector DNA to insert DNA was 1:5 and usually 50 ng of 
linearized dephosphorylated vector DNA was used. 
 
2.2.8 Transformation of DNA in bacteria 
The recombinant plasmids were transferred and amplified in bacterial strains by bacterial 
transformation. In this technique the plasmid is introduced into bacteria and replicated by the 
bacterial DNA polymerases independently of the host cell chromosomes. In the present study 
XL1-Blue supercompetent cells (Stratagene) were used. For heat shock transformation 40 µl 
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XL1-Blue supercompetent cells were thawed on ice in a 1.5 ml tube, mixed with 0.8 µl β-
mercaptoethanol for increasing the transformation efficiency, and incubated for 10 min on ice 
with gentle shaking every 2 min. Subsequently, 7 µl of the ligation mixture were added and 
the tube was incubated on ice for 30 min. As negative control one tube was left without 
ligation mixture. The tube was heat-pulsed in a 42 °C water bath for 45 sec and subsequently 
incubated on ice for 2 min. 450 µl LB medium 8, preheated to 37 °C, were added and the tube 
was incubated at 37 °C for 1 h with shaking at 350 rpm. This step allows bacteria to recover 
from the heat shock and to express the antibiotic resistance gene. 
LB-Amp agar plates were prepared using 15 ml liquefied LB agar, supplemented with 100 
µg/ml ampicillin, due to an ampicillin resistance on the vector, which were poured into 
bacterial plates (100 mm diameter). One plate without addition of ampicillin was used as 
positive control for bacterial growth. The transformation reaction was plated on the LB-Amp 
agar plates (50 and 200 µl transformation reaction, respectively) and the plates were incubated 
bottom-up at 37 °C overnight for bacterial colony formation. 
In order to screen for positive E. coli transformants, carrying the desired plasmid DNA, 
bacterial colonies were picked using autoclaved toothpicks and incubated in 15 ml Falcon 
tubes in 5 ml LB-Amp medium, supplemented with 100 µg/ml ampicillin, at 37 °C overnight 
with shaking for amplification. Mini preparations of plasmid DNA were performed using 
Qiaprep Spin Miniprep (Qiagen) according to the manufacturer’s protocol as described above 
(chapter II.2.2.1), followed by restriction analysis (chapter II.2.2.5) to determine the correct 
size of the DNA insert. Finally the authenticity of the DNA sequence was verified by 
sequencing, which was carried out using commercial services (MWG Eurofins). 
 
LB medium 
Trypton (Pepton from Casein) 10.0 g 
Yeast extract   5.0 g 
NaCl   5.0 g 
Aqua dem. ad 1000.0 ml 
 
 
 
LB agar 
Trypton (Pepton from Casein) 10.0 g 
Yeast extract   5.0 g 
NaCl   5.0 g 
Aqua dem. ad 1000.0 ml 
Agar 12.0 g 
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2.3 Protein biochemistry 
2.3.1 Western blot analysis 
2.3.1.1 SDS-Polyacrylamid gel electrophoresis (SDS-PAGE)  
The expression of proteins of interest was investigated with SDS-PAGE followed by western 
blot analysis. For SDS-PAGE the Laemmli sample buffer 99 was used for sample preparation. 
This buffer contains β-mercaptoethanol, which reduces disulfide bonds, and sodium 
dodecylsulfate (SDS) that destroys the secondary and tertiary protein structure and therefore 
leads to negatively charged SDS-protein complexes in a way that a negative charge is applied 
to each protein in proportion to its mass. The negatively charged protein complexes can be 
separated in a polyacrylamide gel as the small proteins migrate faster towards the anode than 
the bigger proteins. 
The polyacrylamide gel was composed of a separating and a stacking gel. First the separating 
gel was prepared containing 10 % polyacrylamide. Ammonium persulfate (APS) functioned 
as initiator for gel polymerization and N,N,N´,N´-tetramethylethylenediamine (TEMED) as 
catalyst. After gel polymerization the stacking gel was prepared containing 4 % 
polyacrylamide. 
Sample preparation for SDS-PAGE: cell lysates were prepared by washing confluent cell 
monolayers with PBS- and subsequent cell lysis with an appropriate amount of Laemmli 
sample buffer (e.g. cell amount of one 6-well: 6 x 105 cells/100 µl). The cell lysates were kept 
on ice for 10 min and could be stored at -20 °C. For electrophoresis the samples were thawed 
on ice, heated at 100 °C for 5 min for protein denaturation and size-separated by SDS-PAGE 
at 0.3 mA/cm2 using the Mighty Small II unit for 8 x 9 cm gels (Amersham Biosciences), 
filled with 1x electrophoresis buffer. A protein standard (Fermentas) was used for size 
determination. 
 
Separating gel 10 % 
Aqua dem. 4.0 ml 
Tris/HCl 1.5 M pH 8.8 2.5 ml 
SDS 10 %   100.0 µl 
Polyacrylamid 30 % 3.3 ml 
APS 10 %  50.0 µl 
TEMED 5.0 µl 
 
Laemmli sample buffer 
Tris  62.5 mM  
SDS 2 % 
Glycerol  25 % 
Bromphenolblau 0.01 % 
(before use add 0.5 % β-Mercaptoethanol) 
Stacking gel 4 % 
Aqua dem. 6.0 ml 
Tris/HCl 0.5 M pH 6.8 2.5 ml 
SDS 10 %   100.0 µl 
Polyacrylamid 30 % 1.3 ml 
APS 10 %  65.0 µl 
TEMED 5.0 µl 
Electrophoresis buffer 5x 
Tris   75.0 g 
Glycine 360.0 g 
SDS   25.0 g 
Aqua dem. ad 5000 ml 
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2.3.1.2 Semi-dry blotting 
The separated proteins were transferred from the polyacrylamide gel to a PVDF-membrane by 
semi-dry blotting. The PVDF-membrane (Amersham Hypond-P; GE Healthcare) and two 
pieces of blotting paper (Gel blotting paper GB003; Whatman) were cut according to the size 
of the gel. The PVDF-membrane was soaked in methanol for 5 sec and subsequently in 
western transfer buffer; the pieces of blotting paper were soaked only in western transfer 
buffer. The following setup was prepared on the blotting unit: blotting paper, membrane, gel, 
blotting paper. The blotting unit was connected to anode and cathode and the proteins were 
electrotransferred from the gel onto the membrane (from negative to positive pole) at 1.1 
mA/cm2 for 90 min. After protein transfer the membrane was washed in washing buffer for 10 
min and then blocked in 1x blocking reagent (Roche) in washing buffer for 1 h.  
 
Western transfer buffer 
Tris   5.8 g 
Glycine   2.9 g 
SDS 10 %   3.7 ml 
Methanol  200 ml 
Aqua dem. ad 1000 ml 
 
2.3.1.3 Protein detection by western blot analysis 
The membrane was incubated overnight at 4 °C with the primary antibody diluted in 0.5x 
blocking reagent (Roche) in washing buffer under gentle agitation. After washing three times 
for 10 min with washing buffer, the membrane was incubated with the horseradish 
peroxidase-labeled secondary antibody, diluted in 0.5x blocking reagent (Roche) in washing 
buffer for 1.5 h, at room temperature under gentle agitation. Afterwards, the membrane was 
washed three times for 10 min with washing buffer. Detection of the proteins was performed 
using the enhanced chemiluminescence (ECL) detection system kit (Applichem), which is 
based on the emission of light during the oxidation of luminol by hydrogen peroxide, 
catalyzed by the enzyme horseradish peroxidase (HRP). The kit contains two solutions, 
luminol substrate and peroxide solution, which were mixed in a 1:1 ratio. The membrane was 
incubated in this mixture and proteins were observed using a Digital CCD Camera that was 
connected to a computer with the Wasabi imaging software (Hamamatsu Photonics). 
Used antibodies and their dilution factors are specified in table II.9. 
 
Washing buffer 
PBS 1x 
Tween 0.1 % 
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Table II.9: Antibodies used for western blot analysis and their dilution factors 
Primary antibody Dilution Secondary antibody Dilution 
Cx43 (polyclonal) 1:1000 Anti-rabbit 1:2000 
Cortactin (monoclonal) 1:500 Anti-mouse 1:2000 
GAPDH (monoclonal) 1:5000 Anti-mouse 1:5000 
GFP (polyclonal) 1:2000 Anti-rabbit 1:3000 
NOV (CCN3) (polyclonal) 1:500 Anti-goat 1:2000 
 
2.3.1.4 Membrane stripping 
The primary and secondary antibodies can be removed from a western blot membrane by 
stripping. This is recommendable when detecting several antigens on one western blot. For 
stripping the antibodies, the membrane was incubated in stripping buffer for 1 h at room 
temperature under gentle agitation. After blocking for 1 h in 1x blocking reagent (Roche) in 
washing buffer, the blot could be incubated with the next desired primary antibody. 
 
Stripping buffer (pH 2.8) 
Glycine    15.01 g 
NaCl    29.22 g 
Aqua dem. ad 1000 ml 
 
2.3.2 Immunoprecipitation 
Immunoprecipitation is a method for identifying complexes of interacting proteins in cell 
extracts by using an antibody specific for one of the proteins to precipitate the complex. 
Affinity reagents that bind to the antibody are coupled to a solid matrix and are then used to 
drag the complex out of solution. If the protein is associated tightly enough with another 
protein, while captured by the antibody, the partner precipitates as well. Cell lysates were 
prepared by washing a confluent cell monolayer (culture plate 10 mm diameter; about 5 x 106 
cells) with ice-cold PBS-, subsequent adding of 1 ml ice-cold Triton X-100 lysis buffer and 
incubation on ice for 10 min. Cells were scraped off the plate using a cell scraper, transferred 
into a 1.5 ml tube, and incubated on ice for additional 20 min. Afterwards, they were 
centrifuged for 10 min at 10,000 rpm and 4 °C. The supernatant was transferred to a fresh 1.5 
ml tube and the pellet consisting of unsolved cell particles and membranes, was solved in the 
remaining supernatant by sonication (one pulse for 2 sec at 10 % output power, level 3.5). The 
samples were reunited and again centrifuged for 10 min at 10,000 rpm and 4 °C. The cell 
lysates (500 µl) were then incubated with the appropriate magnetic protein beads (50 µl; 
µMACS Micro beads, Miltenyl Biotec) and the specific antibody (5 µg) on ice for 30 min, 
II Materials and Methods 44 
followed by an additional incubation step at 4 °C overnight to allow the formation of a 
protein-antibody-beads-complex. Immunoprecipitation was performed using a magnetic 
separation unit (µMACS Separation unit, Miltenyl Biotec) and µ Columns (MACS, Miltenyl 
Biotec). The columns were washed with 200 µl Triton X-100 lysis buffer and subsequently 
the samples were loaded on the columns. The magnetic beads and bound proteins attached to 
the magnetic column, while the rest of the sample flowed through. The columns were washed 
four times with 200 µl Triton X-100 lysis buffer and once with 100 µl low salt buffer. The 
specific bound proteins were solved from the column by adding 20 µl Laemmli sample buffer, 
pre-heated to 100 °C, and incubation for 5 min. Afterwards, 50 µl Laemmli sample buffer, 
pre-heated to 100 °C, were added and the sample was completely eluted from the column. 
The samples were boiled again at 100 °C for 5 min and immediately investigated by SDS-
PAGE and western blot analysis (chapter II.2.3.1). Antibodies, used for immunoprecipitation, 
and appropriate protein beads are specified in table II.10. 
 
Table II.10: Antibodies and appropriate protein beads used for immunoprecipitation 
Antibody Protein beads 
Cx43 (polyclonal) Protein A 
Cortactin (monoclonal) Protein G 
GFP (polyclonal) Protein A 
NOV (polyclonal) Protein G 
 
Triton X-100 lysis buffer (pH 8.0)  
NaCl   150 mM (0.87 g) 
Triton X-100 1 % 
Tris HCl     50 mM (0.60 g) 
Aqua dem. ad 100 ml 
 
 
Low salt buffer 
Tris HCl 20 mM (0.24 g) 
Aqua dem. ad 100 ml 
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2.4 Confocal laser scanning microscopy  
In this study a confocal laser scanning microscope (TCS SP5; Leica) was used, which was 
equipped with one argon (488 nm) and two helium-neon (543 and 633 nm) lasers. A confocal 
laser scanning microscope uses point illumination by a laser, thus only one specific plane of 
the sample is in focus (focal plane). Additionally, a pinhole arranged in front of the detector 
eliminates out of focus signals, resulting in an increased optical resolution of the image. The 
emitted fluorescence from the focal plane is detected by a photomultiplier tube (PMT) (Figure 
II.6). Confocal scanning of sequential levels of the sample allows reconstruction of a three-
dimensional image. 
 
Figure II.6: Principle of a confocal laser scanning microscope 
The sample is illuminated pointwise by a laser and, additionally, a pinhole in front of the detector allows 
detection of only signals of the sample in focus (focal plane) and eliminates out of focus signals thus increasing 
the optical resolution of the image. 
 
2.4.1 Immunofluorescence staining 
Besides detection by western blot analysis, proteins can also be determined by 
immunofluorescence. This technique offers the advantage to visualize localization of the 
proteins and also colocalization with other proteins within the cell. Specific secondary 
antibodies are used, labeled with a fluorophore (e.g. Alexa Fluor), which can be detected by 
excitation at a specific wavelength using a laser. 
For immunofluorescence stainings, HeLa cells were seeded in cell culture medium on glass 
cover slips (15 mm diameter). The next day the medium was removed and the cells were 
washed twice with PBS supplemented with magnesium and calcium ions (PBS+). The cells 
Objectiv 
lens 
Z 
Above focal-plane (out of focus) 
Focal-plane (in focus) 
Below focal-plane (out of focus) Sample (x,y,z) 
Laser 
Pointwise 
illumination 
Beam 
splitter 
Pointwise 
detection 
Confocal 
pinhole 
Detector 
II Materials and Methods 46 
were fixed with 3.5 % formaldehyde solution in PBS+ for 20 min. After washing twice with 
PBS+, the cells were permeabilized with 0.1 % TritonX-100 in PBS+ for 5 min. 
Subsequently, the cells were washed twice with PBS+ and then incubated with 1 % BSA in 
PBS+ for 1 h at room temperature to block unspecific protein bindings. Afterwards, the cells 
were incubated with the primary antibody diluted in 0.2 % BSA in PBS+ overnight at 4 °C 
(except for the cortactin antibody, which was incubated with the cells at 37 °C and 5 % CO2). 
After washing three times with PBS+, the cells were incubated with either an Alexa Fluor 
488-coupled or an Alexa Fluor 546-coupled secondary antibody, diluted 1:200 in 0.2 % BSA 
in PBS+, for 45 min at room temperature. As negative control only secondary antibody was 
added to one glass cover slip. Afterwards, the cells were washed three times with PBS+ and 
the glass cover slips were placed cell-side down in a drop of Immu-Mount mounting solution 
on a microscope slide. After drying, the glass cover slips were sealed with nail polish. The 
cells were observed by LSM using a 63-fold oil objective and different zoom factors. Used 
antibodies and their dilution factors are specified in table II.11. 
 
Table II.11: Antibodies used for immunofluorescence stainings and their dilution factors 
Primary antibody Dilution Secondary antibody Dilution 
Cx43 (polyclonal) 1:100 Anti-rabbit-Alexa Fluor 488 1:200 
Cortactin (monoclonal) 1:50 Anti-mouse-Alexa Fluor 546 1:200 
GFP (polyclonal) 1:100 Anti-rabbit-Alexa Fluor 488 1:200 
 
Phosphate buffered saline (PBS+) 
NaCl  8.0 g 
KCl  0.4 g 
Mg2SO4 x 7 H2O  0.074 g 
MgCl x 6 H2O  0.074 g 
CaCl2  0.138 g 
Na2HPO4 x 2 H2O  0.15 g 
KH2PO4  0.06 g 
Glucose  1.0 g 
NaHCO3  0.3 g 
Aqua ad iniectabilia ad 1000.0 g 
 
2.4.2 Staining of the actin cytoskeleton 
The actin cytoskeleton can be stained using phallotoxins. These phallotoxins were isolated 
from the deadly Amanita phalloides mushroom and are bicyclic peptides, which bind to F-
actin. In this study Alexa Fluor 488-coupled phalloidin with an excitation wavelength of 495 
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nm and Alexa Fluor 546-coupled phalloidin with an excitation wavelength of 556 nm were 
used. 
 
2.4.2.1 Staining of migrating HeLa cells 
Cells were plated in cell culture inserts for wound healing (chapter II.2.1.5) in an 8-well µ-
slide (Ibidi). After migration for 24 h, the medium was removed and the cells were washed 
twice with PBS+ and subsequently fixed with 3.5 % formaldehyde in PBS+ for 20 min. After 
washing twice with PBS+, the cells were permeabilized with 0.1 % TritonX-100 in PBS+ for 
5 min. Unspecific bindings were blocked with 1 % BSA in PBS+ for 30 min. Subsequently, 
the cells were stained with 5 µl Alexa Fluor-coupled phalloidin diluted in 200 µl 1 % BSA in 
PBS+ for 30 min at room temperature. Afterwards, the cells were washed three times with 
PBS+. After the last washing step 200 µl PBS+ were left on the cells and they were observed 
by LSM. The length of individual filopodia of a single cell was determined using the Zeiss 
Axiovision software and the distance from the filopodium starting point at the cell membrane 
to its tip was measured. The amount of the measured values equates the quantity of filopodia 
per single cell. 14 cells in four independent experiments were analyzed for each transfected 
HeLa cell population. 
 
2.4.2.2 Staining of HeLa cells after inhibition of p38 MAPK 
HeLa 43 and HeLa CTL cells were seeded on glass cover slips (15 mm diameter) in a 24-
well-plate, in a way that they are about 50 % confluent the next day. Then they were 
incubated overnight with cell culture medium containing only 0.5 % NBCS. The next day, 
half of the cells were incubated for 1 h with the specific p38 MAPK inhibitor SB203580 with 
a final concentration of 25 µM, whereas the other half was left without addition of SB as 
controls. Afterwards, the medium was replaced with cell culture medium containing 10 % 
NBCS and the cells were incubated for further 4 h, half of the cells again after addition of 
SB203580 (25 µM). Subsequently, the cells were fixed and stained as described in chapter 
II.2.4.2.1 and the glass cover slips were placed cell-side down in a drop of Immu-Mount 
mounting solution on a microscope slide. After drying, the glass cover slips were sealed with 
nail polish. Cells were observed by LSM. Analysis of filopodia formation was performed as 
described in chapter II.2.4.2.1 
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3 Statistics 
Each experiment was repeated at least four times and the data of each series is displayed as 
mean values + SEM. For statistical analysis, the software SigmaStat for windows version 2.0 
(Jandel Corporation) was used. The samples were compared with each other by one way 
analysis of variance (ANOVA) followed by the Student-Newman-Keuls test. P-values less 
than 0.05 were considered to be significant. 
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III Results 
1 Generation and functional analysis of truncated Cx43 proteins  
1.1 Generation and separate expression of the N-terminal and the C-
terminal part of Cx43 in HeLa cells 
To analyze which part of Cx43 influences cell migration, cDNAs were created encoding 
either the N-terminal part (aa 1 – 257), which represented the channel building part of Cx43 
(Cx43NT-GFP), or the C-terminal part (aa 257 – 382), representing the cytoplasmic adapter 
part of Cx43 (Cx43CT-GFP). Both truncated proteins were tagged with the green fluorescent 
protein (GFP) in order to detect their localization by fluorescence microscopy and their 
expression by western blot analysis. As controls a cDNA encoding full length Cx43 protein 
tagged with GFP (aa 1 – 382, Cx43-GFP), and also a cDNA encoding only GFP were created. 
HeLa wild-type cells, which do not express connexins and therefore lack gap junctional 
communication, were stably transfected with Cx43NT-GFP (HeLa 43NT-GFP cells), 
Cx43CT-GFP (HeLa 43CT-GFP), Cx43-GFP (HeLa 43-GFP), GFP (HeLa GFP) and the 
empty vector pcDNA4 (HeLa CTL), respectively. Single cell clones were investigated for  
their expression of the appropriate proteins by western blot using a polyclonal antibody 
against GFP. HeLa 43NT-GFP cells showed a protein band at the predicted molecular mass of 
55 kDa (29 kDa 43NT + 26 kDa GFP), HeLa 43CT-GFP at 41 kDa (15 kDa 43CT + 26 kDa 
GFP) and HeLa GFP at 26 kDa. GAPDH was used as loading control (Figure III.1). 
 
 
Figure III.1: Expression of single cell clones of truncated Cx43 proteins 
Single cell clones of stably transfected HeLa cells were investigated for the expression of (A) GFP, (B) 
Cx43NT-GFP, and (C) Cx43CT-GFP by western blot analysis using a polyclonal antibody against GFP. 
GAPDH was used as loading control. 
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The cell clones 2, 6 and 12 of HeLa GFP cells showed a strong expression of GFP. Clone 2 
was selected for further investigations. Since clone 6 of HeLa 43NT-GFP cells was the only 
one (out of 10 selected) expressing the protein with the expected molecular mass, this clone 
was taken for further experiments. Two clones of HeLa 43CT-GFP cells (clone 9 and 10) 
displayed expression of the protein with the expected molecular mass and clone 10 was used 
in further experiments. The expression of the selected cell clones of HeLa 43NT-GFP and 
HeLa 43CT-GFP cells compared to full length Cx43 (without GFP-tag; HeLa 43) and HeLa 
CTL is shown in figure III.2. HeLa 43 cells showed a triple band at the expected protein size 
of 43 kDa which is presumably due to phosphorylation events and conformational changes of 
the protein. HeLa CTL cells showed neither Cx43 nor GFP expression as expected. HeLa 
43NT-GFP and HeLa 43CT-GFP cells showed protein bands at 55 and 41 kDa, respectively 
(Figure III.2). 
 
Figure III.2: Expression of Cx43 and truncated proteins in HeLa cells 
Expression of the selected cell clones of HeLa 43NT-GFP (clone 6) and HeLa 43CT-GFP (clone 10) cells was 
analyzed by western blot using a polyclonal antibody against GFP. Subsequent incubation of the membrane with 
a polyclonal antibody against Cx43 revealed expression of Cx43 in HeLa 43 cells. HeLa CTL cells showed 
neither expression of GFP nor Cx43. GAPDH was used as loading control. 
 
Expression of HeLa 43-GFP cell clones was observed by LSM using fluorescence of the 
GFP-tag. One clone out of ten selected single cell clones (clone 8) exhibited expression of the 
GFP-tagged protein and thus these cells were used for further experiments (Figure III.3). 
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Localization of the truncated proteins was analyzed using LSM and compared to the 
localization of the full length Cx43 without GFP-tag, which was detected by 
immunofluorescence staining with a polyclonal antibody against Cx43 (Figure III.3). 
Cx43 in HeLa 43 cells was localized at the membrane mainly at cell-cell contacts and at 
perinuclear regions. Cx43-GFP and Cx43NT-GFP were both also localized at the membrane. 
However, compared to the punctate pattern of Cx43, the expression of the GFP-tagged 
proteins looked differently as they were localized in the whole membrane and not exclusively 
at cell-cell contacts. In contrast, Cx43CT-GFP and GFP were localized in the cytosol and 
partly in the nucleus (Figure III.3). 
 
Figure III.3: Localization of Cx43 and truncated proteins  
Immunofluorescence staining of Cx43 in HeLa 43 cells with a polyclonal antibody against Cx43 and subsequent 
confocal microscopy revealed the typical punctate pattern of Cx43, especially at cell-cell contacts (arrows) and 
at perinuclear regions. No staining was observed using the secondary antibody only (control). GFP fluorescence 
showed membranous localization of Cx43-GFP and of Cx43NT-GFP, whereas Cx43CT-GFP as well as GFP 
alone were localized in the cytosol and partly in the nucleus (scale bars 10 µm). 
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These results indicated that the N-terminal part of Cx43 (aa 1 – 257) containing the four 
transmembrane domains of Cx43 was indeed localized in the cell membrane, required for 
functional gap junction formation. The C-terminal part comprising the cytoplasmic tail of 
Cx43 was localized in the cytosol as expected. 
 
1.2 HeLa 43NT-GFP cells were functionally coupled via gap junctions 
As the channel building part of Cx43 (Cx43NT-GFP) was localized in the cell membrane, cell 
coupling experiments were performed to investigate whether this part of Cx43 is sufficient to 
form functional gap junctions. 
Cell coupling was verified using fluorescent activated cell sorting (FACS). Calcein stained 
donor cells (green), expressing Cx43, Cx43-GFP, Cx43NT-GFP and Cx43CT-GFP, 
respectively, or empty vector transfected cells (CTL) as a control were cocultured for 3 h with 
PKH-26 stained HeLa 43 dye acceptor cells (red). The amount of double stained HeLa 43 
acceptor cells (red and green) was calculated, representing the cell population that have 
coupled with the respective donor cells (Figure III.4). 
 
Figure III.4: Gap junctional cell coupling of Cx43 and truncated Cx43 proteins  
FACS analysis indicated functional cell coupling in HeLa 43, HeLa 43-GFP and HeLa 43NT-GFP cells. In 
contrast, HeLa 43CT-GFP and HeLa CTL cells showed no functional cell coupling. Data are represented as 
percentage of cell coupling, mean + SEM (n = 4 independent cell cultures), (*) p < 0.001 vs. HeLa CTL and 
HeLa 43CT-GFP. 
 
After 3 h of coculture, HeLa 43 cells coupled by 73 ± 4 % with HeLa 43 cells. HeLa 43NT-
GFP showed 41 ± 3 % and HeLa 43-GFP cells 29 ± 10 % functional cell coupling with HeLa 
43, both coupling levels lower compared to HeLa 43/HeLa 43. Neither HeLa CTL nor HeLa 
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43CT-GFP cells showed functional cell coupling (HeLa CTL: 6 ± 1 %, HeLa 43CT-GFP: 8 ± 
2 % double stained cells). 
 
1.3 The C-terminal part of Cx43 increases cell migration of HeLa cells 
To analyze whether the migration enhancing effect of Cx43 is a channel dependent or 
independent effect, cell migration of HeLa cells expressing Cx43 or truncated Cx43 proteins 
was analyzed. Life cell migration was observed for 24 h using an in vitro wound healing 
model and time lapse microscopy. Cell paths of all tracked cell cultures were evaluated 
regarding accumulated and euclidian migration distance, shift of the center of mass, migration 
velocity and directionality. HeLa 43, HeLa 43-GFP and HeLa 43CT-GFP cells showed 
significantly higher accumulated distances (mean ± SEM: Cx43: 252.4 ± 10.3 µm, Cx43-
GFP: 191.1 ± 7.6 µm or Cx43CT-GFP: 212.0 ± 15.8 µm) compared to HeLa 43NT-GFP 
(156.7 ± 16.5 µm) or HeLa CTL (142.4 ± 7.1 µm) cells (Figure III.5). 
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Figure III.5: Analysis of accumulated distance of transfected HeLa cells  
HeLa 43, HeLa 43-GFP and HeLa 43CT-GFP cells showed higher accumulated distances compared to HeLa 
43NT-GFP and HeLa CTL cells. Data are represented as means + SEM (n = 5 independent cell cultures), (*) p < 
0.001 vs. HeLa CTL and HeLa 43NT-GFP. 
 
Similarly, regarding the euclidian distances, which is the shortest distance from the start to the 
end point, HeLa 43 and HeLa 43CT-GFP cells showed significantly higher values compared 
to HeLa 43NT-GFP and HeLa CTL (mean ± SEM: HeLa 43: 219.8 ± 11.9; HeLa 43CT-GFP: 
156.3 ± 10.2 µm; HeLa 43NT-GFP: 109.6 ± 12.9 µm; HeLa CTL: 114.5 ± 7.9 µm). 
Evaluation of the directionality revealed similar results as the euclidian distance: HeLa 43 had 
significantly higher directionality (0.97 ± 0.01) during migration compared to HeLa CTL cells 
(0.80 ± 0.02). HeLa 43CT-GFP cells exhibited significantly higher directionality (0.77 ± 0.02) 
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compared to HeLa 43NT-GFP cells (0.70 ± 0.03). HeLa 43-GFP (0.73 ± 0.01) also showed a 
tendency towards increased directionality compared to HeLa 43NT-GFP but the difference 
was not significant (p = 1.0). The migration velocity as well as the shift of center of mass of 
HeLa 43, HeLa 43-GFP and HeLa 43CT-GFP cells was higher compared to HeLa CTL or 
HeLa 43NT-GFP cells. These results were comparable to the results of the accumulated 
migration distances (data not shown). 
Taken together all numerical migration parameters (accumulated and euclidian distance, 
velocity, directionality and center of mass) were significantly increased in HeLa 43CT-GFP 
cells compared to HeLa 43NT-GFP cells. 
 
2 Generation of further truncated Cx43 proteins:  
Cx43(tr298)-GFP and Cx43(tr336)-GFP 
Migration analysis had shown that the C-terminal part of Cx43 is mediating the migration 
enhancing effect of Cx43. To specify which sequence on the C-terminus is required for this 
effect, cDNAs for two further truncated proteins of Cx43 were constructed, which contained 
either aa 1 – 298 (Cx43(tr298)-GFP) or aa 1 – 336 (Cx43(tr336)-GFP), and cloned into the 
plasmid pcDNA4-GFP. 
 
2.1 Expression of Cx43(tr298)-GFP and Cx43(tr336)-GFP in HeLa cells 
HeLa cells were stably transfected with cDNAs encoding either Cx43(tr298)-GFP or 
Cx43(tr336)-GFP. Single cell clones were investigated for their protein expression by western 
blot analysis using a polyclonal antibody against GFP.  
 
 
 
Figure III.6: Expression of Cx43(tr298)-GFP and Cx43(tr336)-GFP 
HeLa cells were stably transfected with Cx43(tr298)-GFP or Cx43(tr336)-GFP and protein expression was 
analyzed by western blot using a polyclonal antibody against GFP. GAPDH was used as loading control. 
 
HeLa cells expressing Cx43(tr298)-GFP showed a single band at the predicted molecular 
weight of 60 kDa (34 kDa Cx43(tr298) + 26 kDa GFP) and HeLa cells expressing 
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Cx43(tr336)-GFP showed a double band at 64 kDa (38 kDa Cx43(tr336) + 26 kDa GFP), 
which might occur due to phosphorylation events (Figure III.6).  
Subcellular localization of Cx43(tr298)-GFP and Cx43(tr336)-GFP was studied using LSM 
(Figure III.7). 
 
Figure III.7: Cx43(tr298)-GFP and Cx43(tr336)-GFP are localized in the membrane 
Fluorescence of the GFP-tag using confocal microscopy at an excitation wavelength of 488 nm revealed 
membranous localization of Cx43(tr298)-GFP as well as of Cx43(tr336)-GFP in stably transfected HeLa cells 
(scale bars 10 µm). 
 
Since both proteins contained the four transmembrane domains like the full length Cx43 and 
Cx43NT-GFP, their localization was expected in the cell membrane. Indeed, confocal 
microscopy revealed cytosolic and membranous localization of Cx43(tr298)-GFP and 
Cx43(tr336)-GFP in stably transfected HeLa cells (Figure III.7). Like in HeLa 43-GFP and 
HeLa 43NT-GFP cells, the proteins were localized in the whole cell membrane in contrast to 
the punctate pattern in the cell membrane only at cell-cell contacts of Cx43. 
 
2.2 Cx43(tr336)-GFP increases cell migration of HeLa cells 
Cell migration was analyzed as described above. HeLa 43(tr336)-GFP cells showed 
significantly increased accumulated migration distances (186.07 ± 9.16 µm) compared to 
HeLa 43(tr298)-GFP cells (108.68 ± 6.06 µm) as well as compared to HeLa 43NT-GFP cells 
and HeLa CTL cells (Figure III.8). 
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Figure III.8: HeLa 43(tr336)-GFP cells showed increased accumulated migration distance 
HeLa 43(tr336)-GFP cells showed significantly increased accumulated migration distances compared to HeLa 
CTL and HeLa 43NT-GFP cells, whereas HeLa 43(tr298)-GFP cells showed lower migration distances, 
comparable to HeLa CTL and HeLa 43NT-GFP cells, respectively. Data are represented as means + SEM (n = 5 
independent cell cultures), (*) p < 0.001 vs. HeLa CTL and HeLa43NT-GFP.  
 
The results of the other parameters as euclidian distance, shift of center of mass, velocity, and 
directionality were comparable to the results of the accumulated migration distances (data not 
shown). Migration of HeLa 43(tr336)-GFP cells was significantly enhanced compared to 
HeLa 43(tr298)-GFP cells, HeLa 43NT-GFP cells and HeLa CTL cells. Values for HeLa 
43(tr298)-GFP cells were comparable to HeLa 43NT-GFP and HeLa CTL cells. 
The sequence aa 299 – 336 of the C-terminal tail of Cx43 is therefore presumably required for 
the migration enhancing effect of Cx43. 
 
3 Further restriction of the migration mediating part of Cx43 
3.1 Generation and expression of a small part of the cytoplasmic tail of 
Cx43: Cx43(299-336)-GFP 
To analyze if the sequence aa 299 – 336 of the C-terminal tail of Cx43 is required for the 
migration enhancing effect, a cDNA was created encoding Cx43(299-336) and cloned into the 
plasmid pcDNA4-GFP. HeLa cells were stably transfected and protein expression of single 
cell clones was analyzed by western blots using a polyclonal antibody against GFP. Cells 
expressing Cx43(299-336)-GFP showed a band at the predicted molecular weight of 30 kDa 
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(4 kDa Cx43(299-336) + 26 kDa GFP) and a second band at about 32 kDa, which might occur 
due to phosphorylation events (Figure III.9). 
 
 
Figure III.9: Expression of Cx43(299-336)-GFP in HeLa cells  
HeLa cells were stably transfected with Cx43(299-336)-GFP and protein expression of a single cell clone was 
analyzed by western blot using a polyclonal antibody against GFP. GAPDH was used as loading control. 
 
Localization of Cx43(299-336)-GFP in stably transfected HeLa cells was studied using LSM. 
The protein was localized in the cytosol with a punctate staining indicating an accumulation 
in vesicular compartments (Figure III.10). 
 
Figure III.10: Cx43(299-336)-GFP is localized in the cytosol  
Fluorescence of GFP using LSM revealed cytosolic localization of Cx43(299-336)-GFP in a single cell clone of 
stably transfected HeLa cells, partly increased in vesicular structures (arrows). Scale bar 10 µm. 
 
3.2 Cx43(299-336)-GFP increases cell migration of HeLa cells 
Analysis of the migratory behavior of HeLa 43(299-336)-GFP cells revealed increased 
accumulated distances (185.89 ± 8.11 µm) compared to HeLa 43NT-GFP and HeLa CTL 
cells. The values were comparable to those from HeLa 43-GFP and HeLa 43(tr336)-GFP 
(Figure III.11). 
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Figure III.11: HeLa 43(299-336)-GFP cells showed increased accumulated migration 
distances 
HeLa 43(299-336)-GFP cells showed significantly increased accumulated migration distances compared to HeLa 
CTL and HeLa 43NT-GFP cells, similar to HeLa 43(tr336)-GFP cells. Data are represented as means + SEM (n 
= 5 independent cell cultures), (*) p < 0.001 vs. HeLa CTL and HeLa 43NT-GFP. 
 
These results indicate that the sequence aa 299 – 336 of the C-terminal tail of Cx43 is 
mediating the migration enhancing effect of Cx43, which might be due to either one or 
several phosphorylation events taking place at this sequence or due to protein interactions. 
Accumulation of this sequence in vesicles might partially inhibit these events, but 
nevertheless the migration enhancing effect is clearly observable. 
 
4 Analysis of protein-protein interactions of Cx43 with cortactin 
and NOV 
Our results indicated that the migration enhancing effect of Cx43 is independent of its channel 
forming capacity, but mediated by the cytoplasmic C-terminal part. Moreover, the sequence 
responsible for the enhanced migration could be narrowed down to a small part of the 
cytoplasmic tail of Cx43 (aa 299 – 336). To analyze the mechanism of the migration 
enhancing effect of Cx43, possible protein-protein interactions were investigated. Literature 
searches for proteins, which have been shown to influence cell migration and also to interact 
with Cx43, revealed two interesting candidates: the actin-binding proteins cortactin 17 65 174 
and NOV 123 110 45 48 165. 
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4.1 Colocalization of cortactin and the C-terminal part of Cx43 in HeLa 
cells 
In order to find out if an interaction of cortactin with Cx43 is necessary for the migration 
enhancing effect, we first analyzed the localization of both proteins in migrating HeLa cells 
and, furthermore, identified the potential interacting region. Therefore, after serum-stimulated 
migration for 24 h, HeLa 43-GFP, HeLa 43NT-GFP and HeLa 43CT-GFP cells were stained 
with a polyclonal antibody against GFP and a monoclonal antibody against cortactin and 
observed by LSM. In migrating cells cortactin was mainly localized at the leading edge and in 
membranous protrusions. As Cx43-GFP was also localized at the leading edge and in 
membranous protrusions, both proteins showed colocalization in these regions (Figure III.12). 
 
Figure III.12: Colocalization of cortactin and Cx43 in migrating HeLa 43-GFP cells  
Immunofluorescence stainings using a polyclonal antibody against GFP (AF488 (green)-coupled secondary 
antibody) and a monoclonal cortactin antibody (AF546 (red)-coupled secondary antibody) revealed 
colocalization of Cx43-GFP and cortactin especially at the leading edge and in filopodia of migrating cells 
(arrows). Incubation with secondary antibody AF546 only (control) showed no staining (scale bars 10 µm). 
 
In migrating HeLa 43CT-GFP cells the C-terminal part of Cx43 was not only localized in the 
cytosol, but also partly at the leading edge and also in filopodia. In these regions a 
HeLa 43-GFP 
Cx43-GFP Cortactin Overlay Transmission 
Control Control 
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colocalization with cortactin was visible. As the N-terminal part of Cx43 in HeLa 43NT-GFP 
was localized in the membrane per se, colocalization with cortactin was also observed (Figure 
III.13). 
 
Figure III.13: Colocalization of cortactin and the N-terminal or the C-terminal part of 
Cx43 in migrating HeLa cells 
Immunofluorescence stainings using a polyclonal antibody against GFP (AF488 (green)-coupled secondary 
antibody) and a monoclonal antibody against cortactin (AF546 (red)-coupled secondary antibody) revealed 
colocalization of the C-terminal part of Cx43GFP and cortactin, especially at the leading edge and in filopodial 
structures of migrating cells (arrows), whereas it was not evident if the N-terminal colocalizes with cortactin as it 
is localized in the membrane per se (scale bars 10 µm). 
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To further elucidate whether colocalization is attended by direct interaction of the proteins, 
immunoprecipitation studies were performed. 
 
4.2 The C-terminal part of Cx43 and cortactin are part of a complex 
The immunofluorescence stainings had shown colocalization of full length Cx43-GFP with 
cortactin, but it remained unclear which part of Cx43 colocalized with cortactin. Therefore, 
immunoprecipitation studies were performed using cell lysates of HeLa 43, HeLa 43NT-GFP 
and HeLa 43CT-GFP cells which were incubated with a monoclonal antibody against 
cortactin and analyzed by western blots using polyclonal antibodies against Cx43 and GFP. 
Interaction of cortactin could be demonstrated with full length Cx43 (band at 43 kDa) and the 
C-terminal part (band at 41 kDa) but not with the N-terminal part of Cx43. 
Immunoprecipitation of the same cell lysates with a polyclonal antibody against Cx43 and 
subsequent western blot analysis using a monoclonal antibody against cortactin revealed the 
same results (Figure III.14).  
 
 
Figure III.14: The C-terminal part of Cx43 interacts with cortactin 
(A) Immunoprecipitation of cell lysates with cortactin antibody followed by western blots with an antibody 
against Cx43 showed interaction with Cx43, especially with the C-terminal part, whereas the N-terminal part did 
not show a band after subsequent incubation with an antibody against GFP. (B) Immunoprecipitation of cell 
lysates with a polyclonal antibody against Cx43 and subsequent western blot analysis using antibodies against 
cortactin or Cx43 showed the same results (representative western blot of five independent experiments). 
 
Next, we wanted to investigate which part of the C-terminus interacts with cortactin. 
Therefore, immunoprecipitation studies were performed for the C-terminus truncated proteins 
Cx43(tr298)-GFP and Cx43(tr336)-GFP. Immunoprecipitation of cell lysates with a 
monoclonal antibody against cortactin followed by western blot studies using a polyclonal 
antibody against GFP showed an interaction of Cx43(tr298)-GFP (band at 60 kDa) as well as 
of Cx43(tr336)-GFP (band at 64 kDa) with cortactin (Figure III.15). Thus, the interaction of 
cortactin with Cx43 probably takes place at the sequence aa 257 – 298 of the C-terminal part. 
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Figure III.15: Both C-terminus truncated Cx43 proteins interact with cortactin  
Immunoprecipitation of cell lysates with a monoclonal antibody against cortactin followed by western blot 
detection using a polyclonal antibody against GFP revealed that Cx43(tr298)-GFP as well as Cx43(tr336)-GFP 
interacts with cortactin (representative western blot of five independent experiments). 
 
4.3 The C-terminal part of Cx43 and NOV are part of a complex 
We further wanted to investigate which part of Cx43 interacts with NOV. Therefore, cell 
lysates of HeLa CTL, HeLa 43, HeLa 43NT-GFP, HeLa 43CT-GFP, HeLa 43(tr298)-GFP 
and HeLa 43(tr336)-GFP cells were prepared and immunoprecipitation studies were 
performed using a polyclonal antibody against NOV. Subsequent western blot analysis with a 
polyclonal antibody against GFP to detect the GFP-coupled proteins revealed that the C-
terminal part and not the N-terminal part of Cx43 interacted with NOV (Figure III.16; band at 
41 kDa). Moreover, both C-terminus truncated proteins Cx43(tr298)-GFP and Cx43(tr336)-
GFP showed an interaction with NOV (Figure III.16; bands at 60 and 64 kDa).  
  
Figure III.16: Interaction of the C-terminal part of Cx43 with NOV  
Immunoprecipitation with a polyclonal antibody against NOV of cell lysates followed by western blot detection 
using a polyclonal antibody against GFP revealed that Cx43CT-GFP, Cx43(tr298)-GFP as well as Cx43(tr336)-
GFP interacted with NOV (black boxes in the upper blot), whereas the N-terminal part and the empty vector did 
not. The subsequent incubation of the membrane with a polyclonal antibody against Cx43 showed interaction of 
Cx43 with NOV (black box in the lower blot; representative western blot of five independent experiments). 
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Cell lysates of HeLa CTL served as controls and showed no interaction with NOV. The 
interaction of NOV with full length Cx43 was detected with a polyclonal antibody against 
Cx43 (Figure III.16; band at 43 kDa). 
These results led to the conclusion that cortactin as well as NOV bound to the C-terminal part 
of Cx43. Moreover, both proteins interacted with both C-terminus truncated proteins of Cx43, 
Cx43(tr298)-GFP and Cx43(tr336)-GFP, indicating a protein binding of cortactin and NOV to 
Cx43 at the sequence aa 257 – 298.  
 
5 Influence of Cx43 on the actin cytoskeleton 
5.1 Cx43 and Cx43CT-GFP increase filopodia formation in migrating cells 
Migration of cells requires a dynamic regulation of the actin cytoskeleton. Therefore, the 
effect of Cx43 expression on the actin cytoskeleton in migrating HeLa cells was investigated. 
After serum-stimulated migration for 24 h using cell culture inserts, the actin cytoskeleton of 
HeLa 43, HeLa 43-GFP, HeLa 43NT-GFP, HeLa 43CT-GFP and HeLa CTL cells was stained 
with phalloidin (Figure III.17). For a better visualization of the actin filament structures the 
maximal projections of the taken images were analyzed. It was noticeable that HeLa 43, HeLa 
43-GFP and HeLa 43CT-GFP cells exhibited higher amounts of cellular protrusions, namely 
filopodia, compared to HeLa 43NT-GFP and HeLa CTL cells, whereas lamellipodia and 
stress fiber formation showed no obvious differences. 
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Figure III.17: Filopodia formation of migrating HeLa cells expressing Cx43 and truncated 
Cx43 proteins  
HeLa 43, HeLa 43-GFP, HeLa 43NT-GFP, HeLa 43CT-GFP and HeLa CTL cells were stained with phalloidin-
AF488 after serum-stimulated migration for 24 h. HeLa 43, HeLa 43-GFP and HeLa 43CT-GFP cells showed 
higher amounts of filopodia compared to HeLa CTL and HeLa 43NT-GFP cells (representative images of four 
independent experiments are displayed, scale bars 10 µm). 
 
Therefore, amount and length of filopodia per single cell of randomly chosen cells without 
direct neighbour cells were evaluated. HeLa 43, HeLa 43-GFP and HeLa 43CT-GFP cells 
showed significantly longer filopodia per single cell compared to HeLa 43NT-GFP cells 
(length of filopodia (mean ± SEM): HeLa 43: 4.46 ± 0.57 µm, HeLa 43-GFP: 4.67 ± 0.1 µm, 
HeLa 43CT-GFP: 5.41 ± 0.87 µm and HeLa 43NT-GFP: 3.78 ± 0.8 µm), but not significantly 
longer compared to HeLa CTL cells (3.96 ± 0.71 µm; figure III.18). 
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Figure III.18: Length of filopodia of migrating HeLa cells expressing Cx43 and truncated 
Cx43 proteins 
Analysis of the length of individual filopodia per cell revealed that HeLa 43, HeLa 43-GFP and HeLa 43CT-
GFP cells showed significantly longer filopodia compared to HeLa 43NT-GFP cells. Data are represented as 
means + SEM (n = 4 independent experiments, 14 randomly selected cells/experiment were analyzed), (*) p < 
0.001 vs. HeLa 43NT-GFP. 
 
Regarding the amount of filopodia, HeLa 43, HeLa 43-GFP and HeLa 43CT-GFP cells 
showed significantly more filopodia per cell compared to HeLa CTL and HeLa 43NT-GFP 
cells (quantity of filopodia per cell (mean ± SEM): HeLa 43: 30 ± 7, HeLa 43-GFP: 25 ± 5, 
HeLa 43CT-GFP: 21 ± 4, HeLa CTL: 12 ± 3, HeLa 43NT-GFP: 13 ± 4; figure III.19). 
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Figure III.19: Quantity of filopodia of migrating HeLa cells expressing Cx43 and 
truncated Cx43 proteins  
Analysis of the quantity of individual filopodia per cell revealed that HeLa 43, HeLa 43-GFP and HeLa 43CT-
GFP cells showed significantly more filopodia per cell compared to HeLa 43NT-GFP and HeLa CTL. Data are 
presented as means + SEM (n = 4 independent experiments, 14 cells/experiment were analyzed), (*) p < 0.001 
vs. HeLa CTL and HeLa 43NT-GFP. 
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Thus, increased migration capacity is associated with enhanced quantity of filopodia, whereas 
the length of each filopodia seemed not to be important for this effect and is anyway in 
variation because of constant assembly and disassembly of the actin structures. 
 
5.2 Inhibition of p38 MAPK decreases filopodia formation in HeLa 43 cells 
As we had shown that Cx43-mediated enhanced cell migration correlated with increased 
filopodia formation (chapter III.5.1) and also with higher activation of p38 MAPK 6, we 
therefore investigated whether the enhanced filopodia formation by Cx43 expression is also 
associated with activation of p38 MAPK. Thus, HeLa 43 and HeLa CTL cells were treated 
with the specific p38 MAPK inhibitor (SB203580) for 5 h and subsequently the actin 
cytoskeleton was stained with phalloidin (Figure III.20). Cells, treated with SB203580 
showed less filopodia compared to untreated cells, whereas other actin structures such as 
lamellipodia and stress fibers did not seem to be influenced. 
 
Figure III.20: Filopodia formation of HeLa cells with and without addition of p38 MAPK 
inhibitor 
HeLa 43 and HeLa CTL cells were stained with phalloidin-AF546 after incubation with p38 MAPK inhibitor 
(SB203580) (+ SB) or without p38 MAPK inhibitor (- SB). After inhibition of p38 MAPK the cells showed less 
filopodia (representative images of seven independent experiments are displayed, scale bars 10 µm). 
 
The amount of filopodia per single cell was quantified and the mean average of 12 cells for 
each cell line was calculated.  
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Figure III.21: Quantity of filopodia of HeLa cells with and without addition of p38 MAPK 
inhibitor 
Analysis of the quantity of individual filopodia per cell revealed that HeLa 43 cells, treated with p38 MAPK 
inhibitor (SB203580) (+ SB) showed significantly less amounts of filopodia per cell compared to untreated cells, 
whereas for HeLa CTL cells the difference was not significant. Data are represented as means + SEM (n = 7 
independent experiments, 12 cells/experiment were analyzed), (*) p < 0.001 vs. HeLa 43 (- SB). 
 
HeLa 43 cells, treated with SB203580 showed significantly less amounts of filopodia per 
single cell compared to untreated cells, whereas for HeLa CTL cells the difference was not 
significant. Moreover, the amount of filopodia per cell in HeLa 43 cells after SB203580 
treatment was comparable to that observed in untreated HeLa CTL cells (quantity of filopodia 
per single cell (mean ± SEM): HeLa 43 + SB: 61 ± 6, HeLa 43 -SB: 42 ± 5 , HeLa CTL + SB: 
41 ± 4, HeLa CTL -SB: 33 ± 4; figure III.21).  
 
5.3 Cx43(tr336)-GFP and Cx43(299-336)-GFP increase filopodia formation 
in migrating cells 
Since the expression of the C-terminal of Cx43 influences the actin cytoskeleton by elevated 
formation of filopodia, we wanted to elucidate whether the migration enhancing sequence on 
the C-terminus of Cx43 (Cx43(299-336)) also correlates with an increased filopodia 
formation. Therefore, HeLa 43(tr298)-GFP, HeLa 43(tr336)-GFP and HeLa 43(299-336)-GFP 
cells were allowed to migrate in cell culture inserts for 24 h after stimulation with serum and 
the actin cytoskeleton was stained with phalloidin. It was evident that HeLa 43(tr336)-GFP 
and HeLa 43(299-336)-GFP cells showed higher amounts of filopodia per cell compared to 
HeLa 43(tr298)-GFP cells (Figure III.22), whereas other actin structures such as lamellipodia 
and stress fibers exhibited no obvious differences. 
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Figure III.22: Filopodia formation of migrating HeLa cells expressing C-terminus 
truncated Cx43 proteins 
HeLa 43(tr298)-GFP, HeLa 43(tr336)-GFP and HeLa 43(299-336)-GFP cells were stained with phalloidin-
AF546 after migration for 24 h. HeLa 43(tr336)-GFP and Hela 43(299-336)-GFP cells showed higher amounts 
of filopodia per cell compared to HeLa 43(tr298)-GFP cells (representative images of four independent 
experiments are displayed, scale bars 10 µm). 
 
The amount of filopodia per cell was quantified and the mean average of 12 cells for each 
transfected cell line was calculated. HeLa 43(tr336)-GFP and HeLa 43(299-336)-GFP cells 
showed significantly higher amounts of filopodia per cell compared to HeLa 43(tr298)-GFP 
cells (quantity of filopodia per cell (mean ± SEM): HeLa 43(tr336)-GFP: 26 ± 5, HeLa 
43(299-336)-GFP: 26 ± 5, HeLa 43(tr298)-GFP: 12 ± 3; figure III.23). 
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Figure III.23: Quantity of filopodia of migrating HeLa cells expressing Cx43(tr298)-GFP, 
Cx43(tr336)-GFP and Cx43(299-336)-GFP  
Analysis of the quantity of individual filopodia per cell revealed that HeLa 43(tr336)-GFP and HeLa 43(299-
336)-GFP cells showed significantly higher amounts of filopodia per cell compared to HeLa 43(tr298)-GFP 
cells. Data are represented as means + SEM (n = 4 independent experiments, 12 cells/experiment were 
analyzed), (*) p < 0.001 vs. HeLa 43(tr298)-GFP. 
 
5.4 Cx43 is localized in filopodia 
We could show in the previous experiments that expression of Cx43 and its C-terminal part 
leads to a higher formation of filopodia in migrating cells. As it has been reported that Cx43 
interacts with the actin cytoskeleton 174 204, we studied whether Cx43 was localized in 
filopodia. For that purpose, HeLa 43 cells were allowed to migrate for 24 h after stimulation 
with serum and Cx43 was detected by immunostainings with an antibody against Cx43 and 
the actin cytoskeleton by stainings with phalloidin.  
 
Figure III.24: Localization of Cx43 in filopodia of HeLa 43 cells  
HeLa 43 cells were stained with a polyclonal antibody against Cx43 (red) and phalloidin-AF488 (green) after 
serum-stimulated migration for 24 h. Cx43 was localized at cell-cell contacts and partly also in filopodia 
(arrows) (representative images of four independent experiments are displayed, scale bars 10 µm) 
 
Cx43 was localized at cell-cell contacts and partly also in filopodia, where it showed 
colocalization with the actin cytoskeleton (Figure III.24).  
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IV Discussion 
 
In the present study the effect of Cx43 on serum-stimulated cell migration in the tumor cell 
line HeLa was studied and whether this was related to gap junction formation. Using structure 
function analysis we could show that Cx43 increases cell migration in HeLa cells in a gap 
junction independent manner and that aa 299 – 336 are required for this effect. We further 
observed that binding of cortactin as well as of NOV, that both regulate cell migration, takes 
place at aa 257 – 299. Therefore we concluded that both proteins are, at least by binding to 
this sequence, not involved in the migration enhancing effect of Cx43. Finally, we could 
demonstrate that Cx43-enhanced cell migration is associated with increased filopodia 
formation, an effect that requires activation of p38 MAPK.  
 
1 Cx43 enhances cell migration in a gap junction independent 
manner 
The current study shows that Cx43 enhances serum-stimulated migration of HeLa cells. For 
migration analysis cell culture inserts were used in which the cells migrated into a defined cell 
free gap. In this assay, simulating wound healing, the cells combined migration and 
proliferation to fill the gap. However, we could exclude a proliferation dependent effect of 
Cx43 as we used live cell imaging and tracked the cell path of single cells. We measured 
different migration parameters for each cell independently of the cell proliferation rate. This 
was a clear advantage compared to measuring the area which had been filled by migrating 
cells after different time points. For that analysis possible differences in the cell proliferation 
rate among the different cell lines would be more relevant and may lead to misinterpretations. 
Moreover, it has been shown that expression of Cx43 reduces cell proliferation 69 126 30 48. 
A migration enhancing effect of Cx43 has been reported previously for several other cell 
lines, such as rat heart cells H9c2 114, neural crest cells 68 116 204 and C6 glioma cells 4. 
Likewise, downregulation of Cx43 leads to decelerated cell migration in the same cells and 
also in mouse embryonic fibroblasts NIH3T3 195 as well as in endothelial progenitors cells 
(EPC) 6.  
We could show for the first time that expression of the C-terminal tail of Cx43 alone and 
further expression of a small part of the C-terminal tail, namely aa 299 – 336, enhances cell 
migration similar to the full length Cx43 protein. The channel building part of Cx43 
(Cx43NT-GFP), however, exhibited no influence on cell migration. These results clearly 
demonstrate that the migration enhancing effect of Cx43 is gap junction independent and thus 
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confirms previous migration analysis in our lab using modified Boyden chambers 6. In these 
chambers the cells migrate through small pores and thus are not able to form gap junctions 
during migration. Results of those experiments showed that migration of HeLa cells 
expressing Cx43 was increased compared to HeLa cells transfected with the empty vector 6, 
suggesting a gap junction independent effect of Cx43 on cell migration. This fact is also 
confirmed by previous studies showing that Cx43 enhances cell migration independently of 
its channel forming capacity 127 4. Since the channel is not required, adhesion processes or 
exchange of signaling molecules can most likely be excluded as mechanisms for enhancing 
cell migration. The C-terminal tail of Cx43 is naturally localized in the cytosol but adjacent to 
the cell membrane where the N-terminal part is embedded. In the present study HeLa cells 
were stably transfected with the C-terminal part of Cx43 which was localized in the cytosol 
over the whole cell as the protein was overexpressed. The same localization pattern was 
observed for the small part of Cx43 (aa 299 – 336) tagged with GFP, which was also able to 
show a similar migration enhancing effect as the full length Cx43 tagged with GFP. 
Consequently, a membrane bound C-terminal part is not required for the migration enhancing 
effect of Cx43. There are two possibilities why the C-terminal tail could exhibit a similar 
effect on cell migration as the full length Cx43 protein even though the localization was 
different than naturally. Firstly, it could be possible that, as the protein was overexpressed in 
the transfected cells, there was an adequate amount of the C-terminal part localized close to 
the membrane similar to expression of the full-length Cx43 protein. Secondly, the C-terminal 
part may act as a site of protein-protein interactions or as a potential part of a signalosome 
complex that is localized in the cytoplasm, but does not require localization near the 
membrane to cause enhanced cell migration. The C-terminus of Cx43 may also directly or 
indirectly, via another protein, interact with the actin cytoskeleton. This interaction takes 
place in the cytosol and, as demonstrated in the present study, is also possible with a solely 
expressed C-terminus of Cx43. 
That expression of the C-terminal part of Cx43 alone is sufficient to cause similar effects as 
the full length Cx43 protein has been shown with regard to growth inhibition. Thus, 
expression of the C-terminus (aa 257 – 382) in Neuro2A 126, in HeLa 30 and in HEK293 31 
cells, which all do not express Cx43 in their wild-type forms, exhibited similar growth 
inhibition as the full length Cx43 protein, which implicates that the channel function of Cx43 
is not required for this effect.  
Various cytoskeletal proteins have been shown to interact with Cx43. For example, Xu et al. 
observed colocalization of full length Cx43 with α-actinin and drebrin in cardiac neural crest 
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cells 204. Butkevich et al. detected binding of Cx43 to drebrin in pull-down assays using the C-
terminal part of Cx43 (aa 243 – 382) tagged with glutathione S-transferase (GST) and 
membrane fractions of mouse brain homogenate 20. Thus, this binding clearly takes place at 
the C-terminus of Cx43. Furthermore, Cx43 shows interaction with the actin-binding proteins 
cortactin 174 and NOV 123 45 48, which could also be confirmed in the present study by 
immunoprecipitation experiments using whole cell lysates and could further be specified to 
the C-terminal part of Cx43. Therefore, the binding to cortactin and NOV is still possible 
though the C-terminal tail is localized in the cytosol but is not membrane-bound.  
Moreover, adhesion proteins, such as E-cadherin 46, N-cadherin 205 or Zonula occludens-1 
(ZO-1) 70 colocalize with Cx43. N-cadherin interacts with Cx43 at its C-terminal part (aa 227 
– 382) 195 and downregulation of either N-cadherin or Cx43 leads to reduced cell motility in 
NIH3T3 cells 195.  
All these proteins are important in the control of cell migration and Cx43 might contribute to 
this process by either directly binding to those proteins or by indirect binding as part of a 
signalosome complex. Moreover, Cx43 may also directly regulate the actin cytoskeleton 
leading to enhanced cell migration. 
However, there exist a few studies, e.g. by Oliveira et al. and Elias et al. determining that the 
migration enhancing effect of Cx43 is dependent on the gap junction channel. Thus, Oliveira 
et al. presented that after addition of the gap junction blocker carbenoxolon cell migration of 
C6 glioma cells was decreased when seeded in coculture experiments with astrocytes, but 
increased when seeded alone on collagen IV 137. The authors interpret these results in a way 
that homocellular GJC between glioma cells supports intercellular adhesion, whereas 
hetereocellular GJC between glioma cells and astrocytes facilitates tumor cell migration 137. 
Hence, this study intended to analyze cellular communication between different cell types, 
namely glioma cells and astrocytes, and its consequences during tumor formation. Elias et al. 
revealed that the adhesive properties of gap junction channels, but not the function as an 
aqueous channel are required for neuronal migration 38. Thus, both studies used other cell 
lines and methods than we used and focused on the adhesive properties of the Cx43 channel. 
Of note, there are a few studies which indicate that Cx43 decreases cell migration as 
downregulation of Cx43 results in faster wound closure in skin lesions 153 and increased cell 
growth and migration in the breast carcinoma cell line Hs578T 163. These results imply either 
a cell-specific role of Cx43 during cell migration or differences regarding stimulatory 
pathways of migration as in the present study serum-stimulated cell migration was 
IV Discussion 73 
investigated and inhibitory effects of Cx43 on cell migration were mainly determined without 
addition of migration stimulating factors 153. 
 
2 Influences of the GFP-tag on Cx43 expression pattern, cell 
coupling and migration 
The truncated Cx43 proteins generated in the present study were tagged with GFP, because 
this allows studying protein expression and localization in cells without staining 25. It has been 
shown that the protein behavior seemed not to be altered by the GFP-tag 59 190 142. Cx43 
tagged with GFP has also been used in HeLa cells to visualize the structure and assembly of 
gap junctions in living cells 43 102.  
HeLa cells were used in the present study as they have been shown to express no connexins, 
due to epigenetic gene silencing by DNA methylation 82 81 and thus are deficient in gap 
junctional communication 37. Moreover, the cells were suitable to be transfected with Cx43 
and the truncated Cx43 proteins. To determine that Cx43NT-GFP was comparable to full 
length Cx43 in the ability to form functional gap junction channels, cell coupling was 
analyzed by the transfer of the fluorescent dye calcein from HeLa 43 donor cells to HeLa 
43NT-GFP acceptor cells. In these measurements, HeLa cells expressing Cx43NT-GFP or 
Cx43-GFP showed functional cell coupling (43 and 29 %, respectively), albeit to a lesser 
degree compared to HeLa cells expressing wild-type Cx43 (64 %). Truncation of the C-
terminal part or the GFP-tag might be the reason for this phenomenon. Maass et al. showed 
that truncation of the C-terminus (at aa 258) of Cx43 leads to functional gap junction 
channels, but the channel size is increased and the number of channels is reduced, indicating 
that the C-terminal part regulates number and size of gap junction channels 118, which are both 
important for the cell coupling rate. In previous studies gap junction channels of Cx43, tagged 
with GFP at the C-terminus, exhibited slower gating transitions between fully open and closed 
states compared to wild-type Cx43 19 18, which might lead to decreased cell coupling. 
However, another study revealed that fusion of GFP to the C-terminal part of Cx43 did not 
influence cell coupling 78, whereas fusion of GFP to the N-terminus of Cx43 resulted in non-
functional gap junction channels 102. As mentioned above, we used the GFP-tag for expression 
and localization studies of Cx43 protein and the truncated Cx43 proteins within the cell. The 
GFP-tagged proteins, containing the transmembrane domains, were localized in the whole cell 
membrane, whereas wild-type Cx43 was mainly found in the cell membrane at cell-cell 
contact regions. This phenomenon was also described by Hunter et al., who demonstrated that 
fusion of the GFP-tag to the C-terminus of Cx43 resulted in “sheet-like” gap junctions and 
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supposed that the different appearance of the gap junction channels might be due to the fact 
that binding of ZO-1, which is involved in gap junction assembly, to the C-terminus is 
sterically inhibited by the GFP-tag 71. Thus, we suppose that fusion of GFP may impair cell 
coupling to some extent, but, nevertheless, our results clearly show that the N-terminal part of 
Cx43 (Cx43NT-GFP) used in this study is able to form functional gap junction channels, at 
least regarding to the passage of the dye utilized here.  
Fusion of GFP might also be the reason for the fact that migration of HeLa cells expressing 
Cx43-GFP was slightly less compared to wild-type Cx43. As mentioned above, fusion of GFP 
to Cx43 has been shown to influence binding affinity to certain proteins such as ZO-1 52. 
However, another study showed that overexpression of untagged Cx43 in C6 glioma cells led 
to similar increases in cell migration as overexpression of Cx43 tagged with GFP 4, indicating 
that binding of ZO-1 is not associated with enhanced cell migration. If the GFP-tag influences 
migration of HeLa cells, the generated protein Cx43-GFP is the correct control and, compared 
to this, the truncated proteins Cx43CT-GFP, Cx43(tr336)-GFP and Cx43(299-336)-GFP 
exhibited similar migration enhancement, leading to the conclusion that the aa 299 – 336 on 
the C-terminus are indeed required for the migration enhancing effect of Cx43. 
 
3 Cx43 interacts with cortactin 
Cortactin has been described as an actin-binding protein, enriched in cellular protrusions of 
migrating cells 202 194 and is able to enhance cell migration 17 100. Moreover, it interacts with 
Cx43 174 and thus may link Cx43 to the actin cytoskeleton. Using immunofluorescence 
staining we could confirm in the current study that cortactin colocalizes with Cx43 at the 
leading edge and in filopodia of migrating HeLa cells expressing Cx43-GFP. Furthermore, we 
demonstrated that the C-terminal part of Cx43 colocalizes with cortactin at the leading edge 
and also in filopodia of migrating HeLa cells. In this context the cytosolic localization of the 
C-terminus does not seem to alter the binding to cortactin. Anyway, HeLa cells, which were 
stably transfected with Cx43CT-GFP, showed abundant expression of the protein in the 
cytosol. Thus, binding between the C-terminus of Cx43 and other interacting proteins should 
be possible, although the C-terminus is not membrane-bound as it is naturally the case. In the 
present study we showed for the first time that cortactin binds to aa 257 – 299 of Cx43 using 
immunoprecipitation studies. Cortactin is associated with branched lamellipodia and 
invadopodia. It can initiate and stabilize new branched filaments 193 by activation of the 
neuronal N-WASP 87. Concerning the localization of cortactin in filopodia it has been 
observed that cortactin is localized in filopodial tips of neuronal growth cones in Aplysia 
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californica (sea slug) 32 and also in lamellipodia and filopodia of mouse embryonic fibroblasts 
74
. However, in the mouse melanoma cell line B16F1 cortactin is excluded from filopodia 177 
indicating that filopodia localization seems to be cell type dependent. We observed that 
cortactin is localized in filopodia of migrating HeLa cells, but the underlying mechanism and 
the exact function of cortactin there remain to be elucidated. Moreover, using 
immunoprecipitation studies, we investigated that cortactin binds to aa 257 – 299 of Cx43 as 
mentioned above. Interaction of cortactin and Cx43 has been examined in prior studies in 
murine C2C12 myoblasts 174 and also in Sertoli cells of mouse seminiferous epithelium 187 but 
the exact binding sequence has not been observed yet. Cortactin is involved in the process of 
cell migration, as it enhances cell migration 17 65 as well as tumor invasion 28. Likewise, 
downregulation of cortactin results in decreased cell migration, for example, in fibroblasts 100. 
In our study both truncated proteins, Cx43(tr298)-GFP, which had shown diminished cell 
migration, and Cx43(tr336)-GFP, which had shown enhanced cell migration in HeLa cells, 
exhibited binding to cortactin. This binding site therefore is presumably not involved in the 
mechanism of enhanced cell migration. However, we cannot exclude that there exists an 
additional binding site at aa 299 – 336 on the C-terminal tail of Cx43 that might lead to the 
migration enhancing effect or that binding of the whole C-terminus to cortactin is required for 
the effect of increased cell migration by Cx43.  
 
4 Cx43 interacts with NOV 
NOV influences cell migration 110 7 and cell growth 145 147. It either acts intracellularly e.g. by 
upregulating different MMPs 110 7 or remodeling of the actin cytoskeleton 165 or is secreted, 
e.g. after stimulation of the cells with growth factors or transforming oncogenes 13, where it 
can bind to certain integrins 112. Moreover, it shows intracellular interaction with Cx43 and 
links Cx43 to the actin cytoskeleton 45 48. As this interaction might be one reason for Cx43 
enhancing cell migration, we studied binding of NOV to Cx43 and whether this interaction 
influences cell migration in HeLa cells. 
Immunoprecipitation studies in the present work revealed that Cx43 interacts with NOV at the 
C-terminal part and more precisely at aa 257 – 298 of Cx43. It has already been observed by 
immunoprecipitation studies that NOV binds to the C-terminus (aa 257 – 382) of Cx43 in 
Jeg3 cells 48 and in C6 glioma cells 45, which was further specified to aa 280 – 360 of Cx43 
using an immunoprecipitation competition assay with different C-terminus deletion mutants 
in breast cancer cells (Hs578T) 165. We were able to identify the binding sequence of NOV at 
the C-terminal part of Cx43 more closely to aa 257 – 298 of Cx43. This sequence contains 
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two Src binding domains (SH2 at aa 265 and SH3 at aa 274 – 283) 50 and thus Src might form 
a protein complex, in which NOV and possibly also cortactin are involved. However, there 
might also exist an additional binding site for NOV at aa 299 – 336 of Cx43 that could cause a 
migration enhancing effect, indicating that both binding sites are required. This can be 
assumed because of a study using differently C-terminus-truncated Cx43 proteins (aa 1 – 257, 
aa 1 – 264, aa 1 – 273, and aa 1 – 374) which all bind to NOV in immunoprecipitation and 
FRET studies in human embryonic kidney epithelial cells (293T), but only the truncated 
version aa 1 – 374 of Cx43 and the full length Cx43 protein showed the growth inhibition 
effect of Cx43 49. These results indicate that binding of the full length C-terminus to NOV is 
required for this effect which might be analogous to the migration enhancing effect.  
 
5 Cx43 influences the actin cytoskeleton 
The present study demonstrates that enhanced serum-stimulated cell migration in HeLa cells 
due to expression of the C-terminal part of Cx43 and, specifically, that the expression of aa 
299 – 336 of Cx43 is associated with increased filopodia formation per single cell. Indeed, we 
could show that Cx43 is localized in filopodia of migrating HeLa cells. These results suggest 
that Cx43 might influence the actin cytoskeleton. This effect has also been reported in neural 
crest cells 204 and in epicardial cells 155 as in these cells the stress fibers are normally aligned 
in the direction of migration, whereas downregulation of Cx43 leads to stress fibers that show 
no obvious orientation 204 155. Yet, we did not observe such changes in stress fiber alignment 
comparing HeLa cells expressing Cx43 and control cells. Colocalization of full length Cx43 
with the actin cytoskeleton in filopodia was observed recently in LN18 glioma cells which 
endogenously express low levels of Cx43 29. The same study also showed that the C-terminal 
part of Cx43 influences the actin cytoskeleton as cells expressing full length Cx43 or the C-
terminus of Cx43 exhibited numerous actin-rich filopodia that were not visible in cells 
expressing the N-terminal part 29. These results also are in agreement with our results that 
Cx43 leads to an enhanced filopodia formation. Filopodia are involved in cell migration and 
can function as antennae for cells which use them for sensing their environment, leading to 
increased directionality during cell migration 122. Moreover, invasive cancer cells show 
abundant filopodia formation 186. Thus, increased filopodia formation by Cx43 may be one 
aspect leading to the enhanced cell migration found in Cx43 expressing cells. 
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6 Inhibition of p38 MAPK influences the actin cytoskeleton 
The present study shows that inhibition of p38 MAPK leads to significantly reduced 
formation of filopodia in cells expressing Cx43 down to the level observed in untreated empty 
vector transfected cells. These results suggest that activation of p38 MAPK is involved in 
Cx43 mediated filopodia formation. Recently, we could show that addition of the migration-
stimulus serum induced the activation of p38 MAPK in HeLa cells 6. This activation was 
increased in HeLa cells expressing Cx43 or the C-terminal part of Cx43, which both also 
showed enhanced cell migration, compared to cells expressing the N-terminal part of Cx43 or 
empty vector transfected cells. Thus, expression of full length Cx43 or the C-terminal part of 
Cx43 in HeLa cells correlated with an enhanced phosphorylation of p38 MAPK in response to 
the migration stimulus 6. Furthermore, we demonstrated that inhibition of p38 MAPK 
suppressed serum-stimulated migration in those cells to the basal migration levels observed in 
untreated empty vector transfected cells 6. Influences of p38 MAPK on the actin cytoskeleton 
have been determined in various cell types. Thus, inhibition of p38 MAPK by the inhibitor 
SB202190 led to impaired formation of actin stress fibers in TGF-β stimulated mouse 
mammary epithelial cells (NMuMG) 3 and blocked actin polymerization and reorganization in 
PDGF stimulated mouse smooth muscle cells 39. Lately, in murine myoblasts (C2C12) it has 
been observed that inhibition of p38 MAPK prevents the interaction between Cx43 and F-
actin 174, indicating that activation of p38 MAPK plays a role in this context. We could 
confirm these results in the present study by demonstrating that inhibition of p38 MAPK led 
to decreased filopodia formation. Thus, activation of p38 MAPK is involved in Cx43 
mediated influences on the actin cytoskeleton. 
 
7 Future prospects 
In the present work we determined that the migration enhancing effect of Cx43 is gap junction 
independent and thus might be due to Cx43 functioning as an adapter protein or as a part of a 
signalosome complex. In addition, we showed that a sequence on the C-terminus between aa 
299 – 336 of Cx43 is necessary for this process. To further elucidate whether this sequence is 
sufficient and required for the migration enhancing effect, additional migration analysis 
studies with Cx43 mutants lacking or containing mutations in this sequence could be 
performed.  
Moreover, we presented that Cx43 influences the actin cytoskeleton, leading to increased 
filopodia formation. This implies that one or several proteins bind to Cx43 and thus act as 
linker proteins to the actin cytoskeleton and/or Cx43 interacts directly with the actin 
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cytoskeleton. Both actin-binding proteins cortactin and NOV bind to aa 257 – 298 on the C-
terminal part of Cx43. Therefore, this binding does not seem to influence cell migration in 
HeLa cells, but it has to be elucidated whether there is an additional binding site for cortactin 
and/or NOV that might be involved in the migration enhancing effect of Cx43. However, one 
or both of these proteins could link Cx43 to the actin cytoskeleton. Moreover, other actin-
binding proteins which have been shown to interact with Cx43, such as α-actinin, ezrin, 
IQGAP or drebrin 204 could be involved in the migration enhancing effect of Cx43 and 
associated filopodia formation. For example, drebrin is localized in lamellipodia and filopodia 
143
 
144
 and might also be involved in the formation of podosomes in non-neuronal cells 119. 
These results imply an effect of drebrin on the actin cytoskeleton that may therefore link Cx43 
to the actin cytoskeleton as well. New protein candidates could be analyzed by further 
immunoprecipitation studies with the truncated proteins and detected by SDS-PAGE, 
coomassie staining and mass spectrometry or by other pull-down assays. 
Besides interaction of Cx43 with certain proteins, activation of p38 MAPK could be another 
possible mechanism for the enhanced cell migration by Cx43. As mentioned above we 
recently showed that inhibition of p38 MAPK resulted in diminished cell migration in Cx43 
expressing HeLa cells down to the migration levels observed in untreated empty vector 
transfected cells 6. In the current study we present that inhibition of p38 MAPK leads to 
reduced formation of filopodia in cells expressing Cx43 down to the level observed in 
untreated empty vector transfected cells. These findings suggest that enhanced cell migration 
and increased filopodia formation by Cx43 is associated with the activation of p38 MAPK. 
However, this needs to be further elucidated and whether this mechanism also applies for the 
truncated Cx43 proteins. 
The influences of Cx43 on the actin cytoskeleton have to be further clarified, for example 
whether Cx43 either increases assembly of filopodia, possibly by participation in the 
filopodial tip complex, or diminishes the disassembly of filopodia by stabilizing existing 
filopodia. Both processes would result in a higher amount of filopodia per single cell which 
might lead to increased cell migration as filopodia are involved in cell motility and enhanced 
directional cell migration 122. Thus, increased filopodia formation due to Cx43 expression 
might be one reason for enhanced cell migration.  
Several physiological and pathophysiological processes characterized by enhanced cell 
migration such as wound healing and atherosclerosis, are linked with increased expression of 
Cx43 in endothelial 95 94 and smooth muscle cells 149. Especially atherosclerosis is a major 
cause of death in western societies 94 23 24. During the process of atherosclerosis several cells, 
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including dysfunctional endothelium, macrophages, T lymphocytes, and smooth muscle cells, 
migrate into the vessel wall and consequently contribute to the formation of an atherosclerotic 
plaque 94 23 24. Understanding the underlying mechanisms is important for antagonizing this 
migration action. With the present study we could contribute some aspects to the mechanism 
of enhanced cell migration due to Cx43 expression. Thus, it relies on the C-terminal tail of 
Cx43 and the sequence aa 299 – 336 on the C-terminus plays an important role in this context. 
Moreover, cytoskeletal modifications and activation of p38 MAPK are associated with 
enhanced cell migration by Cx43. 
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V Summary 
The gap junction protein Cx43 is widely expressed in mammalian 10 9 191 199 101 83 and non-
mammalian cells 184. Besides its role in forming gap junctions, which allow the direct 
exchange between adjacent cells of molecules up to a molecular weight of 1.8 kDa 91 83, it 
also displays functions as an adapter protein. In fact, various proteins bind to its cytoplasmic 
C-terminal part 50, including actin-binding proteins, such as α-actinin 204 and drebrin 20, 
adhesion proteins, such as E-cadherin 46, N-cadherin 64 or ZO-1 70; and proteins influencing 
proliferation and migration such as NOV 123 45 48 and cortactin 174. Furthermore, Cx43 has 
been shown to influence several cellular processes including cell migration 4 204 and 
proliferation 30 31 138. Accordingly, expression of Cx43 is increased during processes 
associated with enhanced cell migration such as wound healing 95, angiogenesis 189 111, 
atherosclerosis 94 and vascular neointima formation 149. 
In the present study we analyzed the potential influences of Cx43 and some truncated proteins 
of Cx43 on serum-stimulated cell migration and associated cytoskeletal modifications in 
HeLa cells, which do not express connexins in their wild-type form. Using cell culture inserts 
in which the cells migrate into a cell free gap, we observed that the migration enhancing effect 
of Cx43 is gap junction independent and that the sequence aa 299 – 336 on the C-terminus of 
Cx43 is required for this effect. Moreover, we could show that binding of two actin-binding 
proteins, which also have been associated with enhanced cell migration, namely cortactin and 
NOV, takes place at aa 257 – 299 of Cx43. Therefore, this binding alone is presumably not 
involved in the migration enhancing effect of Cx43. The present study revealed further that 
the migration enhancing effect of aa 299 – 336 of Cx43 is associated with increased filopodia 
formation leading to a higher quantity of filopodia per cell. This could be one reason for 
enhanced cell migration due to Cx43 expression as filopodia are involved in cell migration 
and cancer cell invasion 56 122. Moreover, Cx43 mediated increased filopodia formation is 
associated with the activation of p38 MAPK.  
In summary, the enhanced cell migration by Cx43 is gap junction independent and relies on 
the sequence aa 299 – 336 on the C-terminus of Cx43. Moreover, it is associated with 
increased filopodia formation and activation of p38 MAPK. 
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1 Abbreviations 
 
A Alanine 
aa Amino acid 
Abi1 Abl interactor 1 
ADF Actin depolimerization factor 
AF Alexa-Fluor 
Ala Alanine 
AM Acetoxymethylester 
Amp Ampicillin 
APS Ammoniumpersulfate 
Aqua dem. Aqua demineralisata 
Arp Actin-related protein 
Asn Asparagine 
Asp Asparagine acid 
ATP Adenosine triphosphate 
bp Base pair 
BSA Bovine serum albumine 
C Celsius 
Ca2+ Calcium ions 
cAMP Cyclic AMP (Adenosinmonophosphate) 
cDNA Complementary Deoxyribonucleic acid 
CK1 Casein kinase 1 
Cx43 Connexin 43 full length protein (aa 1 – 382) 
Cx43(298)-GFP Connexin 43 truncated protein (aa 1 – 298), GFP-tagged 
Cx43(336)-GFP Connexin 43 truncated protein (aa 1 – 336), GFP-tagged 
Cx43(299-336)-GFP Connexin 43 truncated protein (aa 299 – 336), GFP-tagged 
Cx43CT-GFP Connexin 43 C-terminal part (aa 257 – 382), GFP-tagged 
Cx43-GFP Connexin 43 full length protein (aa 1 – 382), GFP-tagged 
Cx43-NP Connexin 43 non-phosphorylated 
Cx43NT-GFP Connexin 43 N-terminal part (aa 1 – 257), GFP-tagged 
Cx43-P1 Connexin 43 phosphorylated once 
Cx43-P2 Connexin 43 phosphorylated twice 
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DMEM Dulbecco’s modified Eagle medium 
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic acid 
dNTPs Deoxynucleoside triphosphates 
dsDNA Double-stranded DNA 
ECL Enhanced chemiluminescence 
ECM Extracellular matrix 
EDTA Ethylenediaminetetraacetic acid 
e.g. For example 
EGF Endothelial growth factor 
ELISA Enzyme-linked sorbent assay 
Ena/VASP Enabled/vasodilator-stimulated phosphoprotein 
ER Endoplasmic reticulum 
FACS Fluorescent activated cell sorting 
FCS Fetal calf serum 
FGF Fibroblast growth factor 
FRET Fluorescence resonance energy transfer 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GFP Green fluorescent protein 
Gln Glutamine 
Gly Glycine 
GJC Gap junctional communication 
GST Glutathione S-transferase 
GTP Guanosine triphosphate 
h Hour 
HeLa Henrietta Lacks 
HGF Hepatocyte growth factor 
His Histidine 
HRP Horseradish peroxidase 
HUVEC Human umbilical vein endothelial cells 
IL-1β Interleukin-1β 
IP3 Inosintriphosphat 
IRSp53 Insulin-receptor substrate p53 
K+ Potassium ions 
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kDa Kilodalton 
LB Lysogeny broth 
LSM Laser scanning microscopy 
Lys Lysine 
mA Milliampere 
MAPK Mitogen-activated protein kinase 
MAV-1 Myeloblastosis-associated virus type 1 
mDia2  Mammalian Diaphanous-related formin 2 
Min Minute 
MMP Matrix metalloproteinase 
MT1-MMP Membrane type-1 matrix metalloproteinase 
Na+ Sodium ions 
Nap1 Nck-associated protein 1 
NBCS Newborn calf serum 
NM Nanometer 
NOV Nephroblastoma overexpressed 
NPF Nucleation-promoting factor 
NTA N-terminal acidic 
N-WASP Neuronal Wiscott Aldrich syndrome protein 
P Proline 
PAGE Polyacrylamide gel electrophoresis 
PAK p21 activated kinases 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PDGF Platelet derived growth factor 
Pi Inorganic phosphate 
PKC1 Protein kinase C 1 
PMA Phorbol 12-myristate 13-acetate 
PMT Photomultiplier tube 
pS Picosiemens (dimesion unit of the electrical conductance) 
PVDF Polyvinylidenefluoride 
r Rat 
RNA Ribonucleic acid 
rpm Rounds per minute 
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sec Second 
S Serine 
Scar  Suppressor of cAMP receptor 
SDS Sodium dodecylsulfate 
Ser Serine 
SH2 Src homology domain 2 
SH3 Src homology domain 3 
siRNA Small interfering RNA 
TBE Tris borate EDTA 
TEMED N,N,N´,N´-tetramethylethylenediamine 
TGF-β Transforming growth factor β  
Thr Threonine 
TNF-α Tumor necrosis factor α 
TPA 12-O-tetradeconylphorbol-13-acetate 
U Units 
V Volts 
VEGF Vascular endothelial growth factor 
WASP Wiscott Aldrich syndrome protein 
WAVE WASP family Verprolin-homologous protein 
WB Western blot 
WIP WASP-interacting protein 
wt Wild-type 
Y Tyrosine 
ZO-1 Zonula occludens-1 
µ Micro 
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